Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,9580,22,4.82 [0.41-56.16],0.2094211140568417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,9298,19,1.56 [0.70-3.48],0.2731891636151898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,10964,28,0.98 [0.53-1.82],0.947020699081951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,9260,21,1.79 [0.63-5.14],0.2767251923693919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,10908,27,1.09 [0.59-1.98],0.7889208820628717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,10964,28,0.91 [0.55-1.49],0.706893418261328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,9572,22,1.17 [0.88-1.55],0.2914416981969931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,9260,21,1.50 [0.83-2.72],0.1839575311614147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",10741,27,0.87 [0.56-1.33],0.516961714492922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",9417,21,1.52 [1.06-2.20],0.0241747957403411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",9564,22,1.50 [0.99-2.28],0.0570678461465963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,10912,26,2.48 [0.68-9.02],0.1684650176323873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,9572,22,2.63 [0.86-8.06],0.0913936668147966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,10812,26,0.41 [0.18-0.93],0.0331248322251664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,9354,21,0.72 [0.20-2.59],0.6167956172000543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,9537,22,1.44 [1.01-2.06],0.0429995003708572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,11024,27,1.42 [0.80-2.51],0.226170584125895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,9288,20,1.14 [0.46-2.79],0.781872638978321
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,11051,28,1.12 [0.41-3.04],0.8240889442713417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,11101,28,0.91 [0.57-1.45],0.6864976967018472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,9529,22,1.48 [0.57-3.83],0.4228281939724152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,9288,20,0.51 [0.29-0.90],0.0202606082732199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,9260,21,1.81 [0.79-4.15],0.1609443210771948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",10812,26,0.87 [0.37-2.03],0.7459120476270934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,9260,21,1.21 [0.68-2.16],0.5105603511635217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,10831,27,0.20 [0.05-0.89],0.0339686043206883
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,10924,27,0.76 [0.17-3.32],0.7121863814465768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,11024,27,0.91 [0.53-1.58],0.7414087290457427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,9260,21,0.99 [0.46-2.12],0.9779898925646688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,9324,21,0.95 [0.50-1.83],0.8851363775309478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,11159,28,1.20 [0.48-2.96],0.6981930322130826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,10958,28,0.98 [0.44-2.17],0.95459360790175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,9288,20,1.27 [0.39-4.12],0.6910817268487356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,10812,26,0.98 [0.32-3.01],0.9772298460123724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,10944,27,0.74 [0.28-1.94],0.5343505276241265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,11159,28,0.85 [0.35-2.09],0.7211297585299086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,11103,27,0.84 [0.25-2.80],0.7791983801102262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,9537,22,2.32 [0.74-7.32],0.1493838682532832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,9288,20,0.72 [0.17-3.08],0.6533726764714479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,11148,28,0.27 [0.08-0.94],0.0398287266068491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,10964,28,1.06 [0.47-2.40],0.894821641615005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,10812,26,1.13 [0.49-2.63],0.7779021272710847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,9288,20,1.49 [0.56-4.02],0.4259440713942241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,11032,27,0.49 [0.25-0.97],0.0398186171225534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,9577,22,0.24 [0.06-0.95],0.0414396934023895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,9298,19,3.80 [1.42-10.16],0.0077704793532911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,9564,22,0.96 [0.35-2.67],0.9411076381547964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,10741,27,1.48 [0.81-2.71],0.2015412114694609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,9354,21,1.45 [0.79-2.67],0.2341198093298748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,10924,27,1.56 [0.56-4.33],0.3927436575032761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,9354,21,1.05 [0.38-2.95],0.9196618267326896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,9537,22,0.68 [0.31-1.49],0.3349608155391694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,11052,28,0.83 [0.25-2.75],0.7607480015156014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,11089,28,1.30 [0.44-3.87],0.6362190676775825
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,9564,22,0.51 [0.11-2.31],0.3859125518687885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,10964,28,0.80 [0.46-1.39],0.4236239405183968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,11024,27,1.83 [0.50-6.60],0.3588492927016233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,9253,22,0.50 [0.22-1.14],0.0984733660500813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,9354,21,0.44 [0.23-0.85],0.0140711586024322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,10812,26,0.56 [0.36-0.88],0.01244711392224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,9580,22,0.91 [0.50-1.66],0.7608587987267748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,11112,28,1.02 [0.28-3.70],0.9729882394379532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,9260,21,0.97 [0.53-1.80],0.9338068302101782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,9354,21,1.13 [0.71-1.82],0.6038905996836421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFM,Afamin,9580,22,0.33 [0.04-2.56],0.2907858619111017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,10903,27,0.96 [0.56-1.65],0.8916314146942611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,9253,22,1.18 [0.73-1.90],0.5069340958966542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,10975,28,0.84 [0.37-1.95],0.6909311411260107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,10700,27,0.86 [0.61-1.21],0.3755480551984702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,10729,27,0.71 [0.38-1.34],0.2941744503001304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,11052,28,0.65 [0.23-1.86],0.422453430056931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,11159,28,0.90 [0.47-1.71],0.7418065481773028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,9572,22,0.23 [0.02-2.19],0.2028732370054156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,11024,27,0.78 [0.49-1.26],0.314396746508817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,11024,27,1.27 [0.77-2.07],0.3464158274121719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,9298,19,2.21 [0.89-5.51],0.0893217644545177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,9298,19,2.77 [0.93-8.25],0.0673189739487417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,9529,22,0.82 [0.40-1.68],0.586928292053672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,9572,22,0.27 [0.07-1.13],0.073275945970539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,10989,28,0.98 [0.66-1.47],0.9407233149667452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",9317,19,0.60 [0.28-1.28],0.1853687320452673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,10741,27,1.11 [0.59-2.10],0.7388297041090071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,9298,19,1.19 [0.60-2.33],0.6197422034529405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",10950,28,1.12 [0.82-1.52],0.479039166889536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,11024,27,0.89 [0.51-1.55],0.6834552589726587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",9543,22,1.49 [1.02-2.17],0.0377634244639536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,9354,21,1.89 [0.51-7.07],0.3439039305680383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,10741,27,1.25 [0.81-1.94],0.3172139742110441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,9317,19,0.79 [0.36-1.75],0.5607685319591217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,10812,26,1.02 [0.51-2.03],0.9511480410263704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,9288,20,0.74 [0.36-1.52],0.4107492519724303
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,10778,27,1.24 [0.73-2.10],0.41764441922724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,9549,22,1.46 [1.04-2.03],0.0266593520060707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,10681,27,1.42 [0.80-2.52],0.2300841671817364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,11148,28,0.69 [0.12-3.97],0.6764551016918438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,11006,28,0.91 [0.48-1.70],0.756491817792252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",9529,22,0.71 [0.25-2.05],0.5296996756554377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",11006,27,0.59 [0.32-1.08],0.0884669222206212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",9549,22,0.70 [0.27-1.81],0.4601103689492507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,9417,21,0.97 [0.37-2.57],0.952521371563539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,9288,20,0.79 [0.54-1.15],0.2135273431682374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",10964,28,0.80 [0.58-1.09],0.156053316171731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,10831,27,0.35 [0.08-1.58],0.1722040093001257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,11097,28,2.01 [0.36-11.17],0.4256162937079386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,9577,22,1.95 [0.43-8.82],0.3858592429797338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,10778,27,0.77 [0.42-1.40],0.3849621796968523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,9317,19,0.62 [0.20-1.88],0.4002476857386458
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,10964,28,0.42 [0.10-1.78],0.2392216442371527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,10831,27,1.10 [0.53-2.27],0.8049454033051451
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,9354,21,2.81 [1.10-7.16],0.0302617662386952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,9489,22,0.84 [0.34-2.11],0.7150169719937165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,9543,22,0.74 [0.41-1.31],0.2976616909770743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,8973,20,1.12 [0.52-2.42],0.7765352169128094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,10616,26,1.12 [0.54-2.32],0.7535612070330022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,10287,26,1.18 [0.58-2.39],0.6451047271899674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,10992,28,1.44 [0.57-3.64],0.4377183978263802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,10976,28,0.79 [0.54-1.15],0.2156853279359688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,11112,28,1.01 [0.41-2.51],0.9816818796419968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,10849,27,0.69 [0.20-2.34],0.5528801259539562
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,11009,28,0.94 [0.40-2.22],0.8884803327833994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,11031,28,1.14 [0.41-3.12],0.8036019735730973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,11038,28,0.94 [0.45-1.97],0.8614642691620662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,11112,28,0.77 [0.31-1.94],0.5852847958636169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,9260,21,0.89 [0.45-1.74],0.7293361855377372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,9288,20,1.47 [0.88-2.47],0.1403827176625706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,9230,19,0.58 [0.24-1.43],0.2352568968263517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,10741,27,1.41 [0.88-2.26],0.1508683163095044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,9298,19,1.40 [0.61-3.21],0.4311537503539014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,11049,28,1.06 [0.31-3.59],0.9243132256230742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,9304,21,1.31 [0.62-2.77],0.4871577074373125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,10778,27,1.05 [0.68-1.63],0.8221292824382482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,10995,27,1.06 [0.63-1.78],0.8377384971026797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,9174,18,1.56 [0.99-2.45],0.0552971681416121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,11103,27,1.10 [0.68-1.79],0.7007103151054941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,10973,27,1.22 [0.77-1.91],0.3942173731129199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,10743,27,1.43 [0.47-4.35],0.5308718735869086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],10831,27,0.66 [0.29-1.50],0.322012390492182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,11063,28,0.91 [0.30-2.81],0.875472089369828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,9529,22,1.49 [0.95-2.36],0.0849148604285272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,9317,19,1.82 [0.87-3.79],0.1119777070716175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,9537,22,1.76 [1.07-2.88],0.0249424638763659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,9543,22,1.61 [0.77-3.37],0.2044670054248172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,10964,28,0.63 [0.27-1.44],0.2687113098890136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,9504,22,1.01 [0.29-3.52],0.9934131262565709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,11087,28,0.94 [0.52-1.70],0.8442131294969447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,11024,27,1.49 [0.78-2.85],0.2251473333454186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,9580,22,1.07 [0.22-5.08],0.9343597641257684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,9572,22,1.17 [0.52-2.61],0.7067187205209979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,9580,22,1.33 [0.45-3.92],0.6027999479852743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,9572,22,2.68 [0.58-12.31],0.2064358787352824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,9298,19,1.02 [0.36-2.90],0.9658591705527716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,9565,22,0.78 [0.25-2.43],0.6690192347565918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,9142,20,0.67 [0.18-2.50],0.5495343774598671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,9580,22,0.89 [0.42-1.87],0.7530466633731259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,9572,22,1.53 [0.32-7.43],0.595878150977053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,11006,28,0.81 [0.31-2.10],0.6631313574736389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,9572,22,0.55 [0.23-1.30],0.1712286026510516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,11052,28,1.54 [0.48-4.94],0.467888997820439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,10990,28,0.75 [0.45-1.26],0.2834893912091158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,9354,21,1.47 [0.99-2.18],0.0548102372683558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,10935,27,1.53 [0.71-3.29],0.2785337567600482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,9417,21,1.16 [0.63-2.15],0.6262061573847426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,10964,28,0.62 [0.23-1.67],0.3399739367152489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,9537,22,1.47 [0.98-2.19],0.059545575675037
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,9549,22,2.05 [1.21-3.46],0.0073299776292526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,10954,27,0.55 [0.28-1.07],0.079516349951475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",9529,22,1.63 [0.78-3.39],0.1913773381440813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,10741,27,1.23 [0.59-2.57],0.5839068003983108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,10741,27,1.31 [0.80-2.15],0.2829272463260824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,9417,21,1.00 [0.35-2.81],0.9965577754219506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,9354,21,1.68 [1.01-2.79],0.0438450175954186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,9230,19,0.70 [0.34-1.44],0.3374483333258583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,9543,22,1.75 [1.10-2.79],0.0182560035713148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,9549,22,1.39 [0.92-2.11],0.1139817127139428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,11019,27,1.00 [0.72-1.39],0.99931625817983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,9253,22,1.23 [0.74-2.04],0.4336211641779991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,9253,22,0.87 [0.30-2.51],0.7968254297026898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,10778,27,0.41 [0.13-1.29],0.1284676585488753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,9260,21,1.19 [0.66-2.13],0.5641060610972666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,9260,21,2.03 [0.84-4.92],0.1169823651087747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,9253,22,1.14 [0.59-2.23],0.6950051870271392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,10831,27,0.63 [0.22-1.76],0.3766148164525186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,9260,21,1.23 [0.57-2.67],0.5988179363632378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,11006,28,1.06 [0.50-2.22],0.8833043872426625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,10964,28,0.88 [0.48-1.61],0.6697988895963176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,11063,28,1.63 [0.65-4.10],0.3001598977167152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,9253,22,0.18 [0.05-0.66],0.0101227240880227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,10831,27,0.56 [0.20-1.54],0.2621931128975889
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,9494,21,1.89 [0.97-3.67],0.059736801738687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,10944,27,1.35 [0.66-2.77],0.4084450244583154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,10944,27,1.03 [0.32-3.34],0.956985534492018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,9572,22,0.98 [0.21-4.65],0.9774437226144784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,9564,22,0.90 [0.20-3.96],0.8884223461442684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,9549,22,1.93 [1.07-3.47],0.0292677016748696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,9298,19,1.60 [1.05-2.46],0.0306030128274488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,9260,21,0.49 [0.29-0.86],0.0119441955317283
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,10778,27,0.95 [0.54-1.67],0.8627949323447444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,9230,19,0.68 [0.16-2.93],0.6079299001361341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,9537,22,1.55 [0.97-2.47],0.0650251300972529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,10741,27,0.95 [0.53-1.71],0.8741931544923253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,11032,27,1.15 [0.72-1.86],0.5593313290180634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,9260,21,1.29 [0.64-2.59],0.4765923567605182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,9260,21,2.42 [0.97-6.03],0.0573565925095998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,9260,21,0.94 [0.31-2.81],0.9059198432686496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,9230,19,0.32 [0.09-1.17],0.0848300232339891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,9260,21,0.71 [0.30-1.70],0.4407074061013645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",9260,21,0.52 [0.17-1.61],0.2584288116687639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",11052,28,1.13 [0.83-1.53],0.4461289593960258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",10778,27,0.52 [0.21-1.27],0.1519453582029694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,10741,27,0.94 [0.39-2.25],0.8848835995743344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,10964,28,1.48 [0.57-3.88],0.4237726281672835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,10760,27,1.13 [0.69-1.84],0.6358112184406115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,9298,19,1.90 [1.11-3.26],0.0189730879055691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,9260,21,1.09 [0.72-1.65],0.68676160185725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,9537,22,1.12 [0.32-3.93],0.8585249879233349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",9580,22,0.53 [0.05-6.32],0.6191131358826581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,10778,27,1.27 [0.79-2.04],0.3211170560085333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,9253,22,1.01 [0.67-1.52],0.9604953306503698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,9549,22,1.34 [0.64-2.81],0.4385987685158229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,9543,22,1.43 [0.77-2.68],0.2593030108729256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,11019,27,1.00 [0.70-1.42],0.9983688323284492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,11063,28,1.70 [0.50-5.70],0.3936363328494582
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,9549,22,1.64 [0.87-3.06],0.1244594692112655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,10701,28,0.96 [0.61-1.53],0.8716440320087848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,9580,22,1.38 [0.66-2.91],0.3938483451203555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,9260,21,0.81 [0.10-6.34],0.8370356978924955
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",9298,19,1.68 [0.50-5.72],0.4036117661875655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",11052,28,1.04 [0.30-3.54],0.9534175234133676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",11006,28,2.57 [0.69-9.53],0.1583886110963852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,9288,20,1.58 [0.43-5.78],0.4862631327883674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,11019,27,0.83 [0.52-1.33],0.4422466697275483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,10924,27,1.73 [0.72-4.15],0.2194625188627307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,9288,20,1.49 [0.73-3.05],0.278282431778717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,10812,26,0.83 [0.31-2.18],0.6997554261529193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,10741,27,1.26 [0.77-2.06],0.3528179448034223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,10741,27,1.06 [0.32-3.46],0.9271107736675112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,11019,27,1.00 [0.72-1.38],0.9778876553841236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,9543,22,1.02 [0.58-1.82],0.9341073937800422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,9317,19,0.83 [0.42-1.62],0.578693023799705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,10760,27,1.26 [0.88-1.80],0.2127299026769691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,11006,28,1.06 [0.26-4.31],0.931530331439685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,10944,27,1.20 [0.45-3.24],0.7127263604897456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",9564,22,2.12 [0.81-5.54],0.1260999556987596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",9253,22,0.47 [0.15-1.46],0.1905258665733322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,9402,21,1.45 [0.29-7.13],0.6477028520755994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,9537,22,1.78 [1.18-2.69],0.0057110571862309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,9543,22,1.56 [1.03-2.38],0.037429240851073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",11019,27,0.96 [0.43-2.14],0.9262951319502344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,9288,20,1.14 [0.61-2.16],0.6786468014293915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,9230,19,0.93 [0.48-1.82],0.8367332160954251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,9529,22,0.67 [0.23-1.98],0.4732930793718681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,11019,27,1.07 [0.74-1.55],0.7288030522553197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,9577,22,1.19 [0.73-1.96],0.4828993892272651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,9298,19,1.61 [0.82-3.15],0.1635666579210946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,9230,19,0.25 [0.07-0.89],0.0322695317014613
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,9577,22,0.72 [0.45-1.14],0.1579455412011545
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,10726,27,1.14 [0.86-1.51],0.3567532985706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,9253,22,1.42 [0.92-2.17],0.1098810269325892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,9260,21,1.40 [0.27-7.15],0.6873291788627052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,11019,27,1.09 [0.67-1.80],0.7213875057407723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,11006,28,0.95 [0.65-1.38],0.7887980474287917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,10741,27,1.50 [0.91-2.48],0.1139062593413294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,11148,28,1.36 [0.46-3.99],0.5786068535003437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,9288,20,0.54 [0.15-2.01],0.3617853048717249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,9253,22,0.92 [0.50-1.68],0.7867205718958649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,9543,22,1.43 [0.58-3.52],0.4396959116707259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,11006,28,0.87 [0.51-1.46],0.5915949165703492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,9354,21,2.64 [0.57-12.19],0.2144807694919871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,10924,27,0.59 [0.27-1.31],0.1945447023441057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,10792,26,0.80 [0.34-1.87],0.6027571737988429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,9354,21,4.08 [0.92-18.04],0.0633039983221799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,9564,22,1.60 [0.58-4.46],0.3667798110015052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,9288,20,1.60 [0.74-3.49],0.2339660662664192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,10812,26,1.08 [0.24-4.91],0.920966309643246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,9253,22,1.20 [0.64-2.24],0.5744302319590762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,9298,19,2.94 [1.30-6.65],0.0096711850229707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,8966,17,0.90 [0.59-1.39],0.647945435300122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,10987,27,1.15 [0.68-1.93],0.6045883453248171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,9550,22,0.59 [0.27-1.30],0.1887654973140672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,9432,22,1.54 [1.03-2.30],0.0360648080521021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,9417,21,1.10 [0.27-4.46],0.8899043966661123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,9253,22,1.13 [0.36-3.56],0.8401631689089877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,9260,21,1.24 [0.70-2.19],0.4664891944986514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,9260,21,2.01 [0.66-6.08],0.216924862197305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,10778,27,1.17 [0.55-2.47],0.6795986103143914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,9253,22,0.67 [0.21-2.19],0.5130552115196717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,9549,22,2.68 [1.31-5.48],0.0067731907030345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BSG,Basigin,11138,28,0.57 [0.16-2.08],0.3936062457801127
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BSND,Barttin,9230,19,0.39 [0.08-2.02],0.2642581317062381
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,11122,28,0.79 [0.45-1.40],0.427000821480983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,11122,28,0.57 [0.26-1.26],0.1636406568065174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,10741,27,0.91 [0.56-1.47],0.69876812859976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,9580,22,2.49 [0.32-19.65],0.3868570344806161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,9230,19,1.01 [0.60-1.67],0.9797927067155018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,9511,22,0.92 [0.30-2.84],0.8890826090488234
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,11052,28,0.38 [0.10-1.43],0.1526005226355687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,11019,27,0.83 [0.33-2.09],0.6872255275026249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,9230,19,1.24 [0.44-3.47],0.68068769195952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,10778,27,0.51 [0.26-1.02],0.0572110272983345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,9260,21,0.62 [0.15-2.57],0.508364897085125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,11103,28,1.07 [0.23-4.93],0.9325403869473536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",9549,22,0.90 [0.44-1.83],0.7652726655014466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,9288,20,0.29 [0.09-0.90],0.0320262904649228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,11063,28,0.73 [0.33-1.60],0.4301194954002432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,9354,21,0.86 [0.28-2.66],0.7926749409931808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,9549,22,1.75 [0.69-4.46],0.2394192365242979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,9340,21,1.25 [0.50-3.11],0.6343076577351405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,9580,22,0.78 [0.07-8.95],0.8434188758873894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,9564,22,2.55 [0.30-22.07],0.3940923240384092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,9580,22,3.21 [0.52-19.68],0.2079860482311152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2,Complement C2,11052,28,3.97 [0.75-20.96],0.1038155971627008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,10760,27,1.01 [0.45-2.27],0.9733302084934627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,9317,19,1.29 [0.69-2.41],0.4196708720342055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C3,Complement C3,9117,20,1.07 [0.42-2.74],0.8801994515013866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,11032,27,1.32 [0.55-3.20],0.5325212947232216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C5,Complement C5,9580,22,9.27 [1.52-56.72],0.0159574891091338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,9364,21,0.78 [0.21-2.81],0.7013418268864122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,9543,22,0.68 [0.08-5.52],0.7200269380428386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,9580,22,0.31 [0.08-1.13],0.07613091558762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,9572,22,1.10 [0.54-2.25],0.7961716910241503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,9537,22,0.89 [0.54-1.49],0.6687044423755026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,10790,27,0.76 [0.42-1.38],0.3661520698335879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,10741,27,0.70 [0.18-2.75],0.6139905768274132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,10964,28,0.91 [0.31-2.65],0.8612581665280682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,10892,27,1.18 [0.84-1.65],0.3472140742217487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,11112,28,0.27 [0.11-0.65],0.0036404111774012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,10977,28,0.86 [0.52-1.42],0.5429537600705467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,11131,28,1.01 [0.59-1.76],0.9579384536369014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,11148,28,0.75 [0.18-3.02],0.6803713111827856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",10812,26,0.79 [0.52-1.21],0.2745935641598312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,10967,27,1.07 [0.63-1.84],0.7980987357753131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,9417,21,0.92 [0.25-3.44],0.901276242144322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,9288,20,0.79 [0.12-5.07],0.8056247546881952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,11112,28,0.94 [0.44-2.02],0.8793822668151358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,9317,19,0.91 [0.45-1.86],0.8046949024211075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,9253,22,0.59 [0.13-2.72],0.5014702447551409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,9260,21,0.70 [0.25-1.91],0.4811416273233663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,9253,22,0.92 [0.45-1.90],0.8269285425482717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,9549,22,1.81 [1.14-2.89],0.0123063812269037
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,9337,21,1.55 [1.01-2.37],0.0433455194774373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,9317,19,1.27 [0.50-3.27],0.6162636380302766
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,10964,28,1.10 [0.50-2.42],0.8101396252035198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,10778,27,0.56 [0.16-2.02],0.3781952287950297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,10926,27,0.78 [0.46-1.31],0.3477494801197819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,9543,22,0.70 [0.22-2.23],0.5445495997686669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,11083,28,1.03 [0.74-1.42],0.8679356326582297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,9298,19,1.74 [1.03-2.96],0.0400689316942739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,9260,21,0.84 [0.24-2.90],0.7832593215718431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,10741,27,1.60 [0.86-2.99],0.1378596814676383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,9317,19,1.30 [0.66-2.60],0.4497014058222308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,9549,22,1.20 [0.83-1.74],0.3325001940691322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,10987,27,0.51 [0.09-2.93],0.4501774525115994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,10948,28,0.68 [0.38-1.23],0.2017118008698355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,9529,22,1.52 [0.69-3.32],0.2970768606126359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,9543,22,1.21 [0.91-1.61],0.196123304126179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,10778,27,0.67 [0.32-1.38],0.2728563278763303
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,9317,19,1.84 [0.83-4.10],0.1351633449014336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,10778,27,0.98 [0.60-1.60],0.944561343666828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,10778,27,1.07 [0.66-1.72],0.7834091588467382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,11019,27,0.91 [0.55-1.51],0.7199189362710452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,11148,28,1.07 [0.73-1.57],0.7187662380663132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,9417,21,1.02 [0.79-1.31],0.8928317723954676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,9543,22,1.64 [1.07-2.52],0.0242832920270348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,11086,28,0.96 [0.56-1.65],0.8882988303273526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,9288,20,1.32 [0.76-2.29],0.3297644759671634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,9260,21,0.58 [0.18-1.91],0.3717177505076926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAT,Catalase,9433,22,0.87 [0.40-1.88],0.7221323924401264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,11014,27,0.93 [0.57-1.50],0.7542711268719514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,9253,22,1.24 [0.93-1.66],0.148901647845678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,11112,28,1.57 [0.86-2.88],0.1437615536810405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,9298,19,0.54 [0.19-1.55],0.2533923292996214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,9260,21,1.00 [0.34-2.89],0.9944563719145884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,10944,27,0.96 [0.60-1.54],0.8784046244510063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,9543,22,0.90 [0.40-1.99],0.7883016820654709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,9529,22,1.29 [0.62-2.69],0.4987033584491909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,9317,19,1.95 [0.43-8.77],0.384860636287761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,9549,22,0.85 [0.46-1.54],0.5888182628106227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,11024,27,0.56 [0.19-1.63],0.2865161563752716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,9298,19,1.90 [1.12-3.24],0.0178545983842921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,11159,28,0.51 [0.21-1.24],0.1386422396893094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,11140,28,0.59 [0.36-0.98],0.0420663916017032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,10992,28,0.85 [0.36-1.99],0.7084911231438746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,11148,28,0.98 [0.45-2.12],0.95054556883008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,11148,28,1.22 [0.62-2.41],0.557763210365779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,10975,28,0.85 [0.59-1.24],0.4011879486202605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,10879,27,0.91 [0.54-1.53],0.7218295674537138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,11122,28,0.96 [0.70-1.32],0.7847475711723113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,10924,27,0.62 [0.31-1.22],0.162896721314483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,11159,28,1.36 [1.00-1.84],0.0494182719662464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,11052,28,0.46 [0.18-1.18],0.1052857841803361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,10874,28,0.87 [0.45-1.70],0.6882568047832873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,11052,28,0.85 [0.38-1.91],0.7008879846071462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,11038,28,0.72 [0.47-1.11],0.1349678741172161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,11159,28,1.09 [0.55-2.15],0.7994245176512447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,11019,27,0.79 [0.52-1.20],0.2659119691352434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,11024,27,0.86 [0.50-1.46],0.5715625714858086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,10986,27,1.05 [0.59-1.86],0.8716941898009487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,11019,27,1.16 [0.75-1.81],0.5042564611163095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,11014,28,1.20 [0.78-1.84],0.4092819662204429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,11063,28,1.05 [0.76-1.45],0.7801025027893095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,11019,27,1.18 [0.69-2.04],0.5431048101644571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,11097,28,0.89 [0.52-1.52],0.6582307003888425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,10949,28,0.83 [0.53-1.29],0.4025786837693818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,11007,28,0.80 [0.45-1.42],0.4449767740662517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,11124,28,1.49 [0.56-3.95],0.4280269902664614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,11112,28,1.01 [0.43-2.38],0.984417928872708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,11006,28,0.53 [0.21-1.35],0.1828039178949884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,9417,21,2.25 [0.68-7.47],0.1836459237443802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,9288,20,0.98 [0.61-1.57],0.9246104995047862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,10944,27,0.85 [0.41-1.79],0.6719458992089402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,10741,27,0.99 [0.46-2.13],0.9809508771410544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,9537,22,0.55 [0.26-1.18],0.1263830715948882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,11006,28,0.62 [0.26-1.51],0.2951698430787102
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,10805,28,1.25 [0.56-2.82],0.5857082902695518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,11159,28,0.99 [0.48-2.05],0.9865379464206736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,11063,28,0.87 [0.39-1.92],0.7267386374016842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,11006,28,1.19 [0.42-3.37],0.7461821133123621
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,9317,19,1.10 [0.34-3.58],0.8709494317152917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,10991,28,1.10 [0.83-1.47],0.5163405187758241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,11032,27,0.47 [0.14-1.50],0.1997583385848552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,9260,21,0.44 [0.11-1.82],0.2556438745308165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,11019,27,0.81 [0.21-3.11],0.7600089063651071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,10975,27,0.92 [0.35-2.46],0.8731993765305104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,10761,27,0.80 [0.32-1.97],0.6260590998866403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,11033,27,0.77 [0.32-1.82],0.5498596052317473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,11159,28,0.93 [0.41-2.14],0.8648651954627606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,9288,20,1.59 [0.61-4.14],0.3425596105558945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,11159,28,0.68 [0.20-2.35],0.5428714904592478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,9577,22,1.18 [0.43-3.23],0.7487609186182238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,11032,27,0.73 [0.31-1.76],0.4878722583804349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,10944,27,1.23 [0.45-3.34],0.6846937781706658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,10994,28,0.46 [0.22-0.94],0.0337112257117588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,10741,27,0.86 [0.32-2.32],0.7693794745011518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,11024,27,0.92 [0.53-1.60],0.769936794630186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,9354,21,2.00 [0.56-7.15],0.285650957627936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,11122,28,1.09 [0.41-2.93],0.8580709184741971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,11081,28,1.02 [0.43-2.39],0.9679735831838332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,11112,28,0.87 [0.51-1.47],0.6031350695030548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,11006,28,1.23 [0.48-3.11],0.6673628630095236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,10964,28,0.74 [0.22-2.43],0.615865169689302
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,11032,27,1.01 [0.66-1.55],0.9605550421009734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,11085,28,0.54 [0.13-2.20],0.3896720534289226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,9288,20,1.27 [0.53-3.08],0.591937171824894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,10964,28,0.47 [0.16-1.41],0.1781751865448269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,9253,22,0.58 [0.13-2.73],0.4939617613498966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,9417,21,0.63 [0.14-2.80],0.543941975669884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,9288,20,0.81 [0.43-1.53],0.5154217527128695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,10999,27,0.34 [0.09-1.23],0.1004478547843208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,11000,28,0.98 [0.50-1.90],0.9503335995427432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,11159,28,0.95 [0.62-1.43],0.792951321361751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,10961,28,0.66 [0.19-2.25],0.5073721834350469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,11038,28,0.58 [0.18-1.84],0.3559186959295373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,11097,28,0.33 [0.12-0.93],0.0353549932712715
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,10648,27,0.59 [0.14-2.44],0.467268662735592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,10971,28,0.16 [0.03-0.94],0.0422241015876401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,10619,28,0.85 [0.16-4.46],0.84729977810035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,9537,22,0.87 [0.37-2.04],0.7438251348597092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,11138,28,0.48 [0.26-0.91],0.0243499602889964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,10924,27,0.99 [0.50-1.95],0.970106215594752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,10962,27,1.00 [0.68-1.47],0.984360055315072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,9274,20,0.72 [0.25-2.11],0.5480143879355769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,11019,27,0.97 [0.44-2.11],0.9292631418680596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,9354,21,2.16 [0.85-5.52],0.1075547130165898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,11122,28,0.57 [0.20-1.61],0.2898099732206161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,11159,28,0.90 [0.40-2.03],0.7964499320442013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,9564,22,0.45 [0.12-1.69],0.2365800678506999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,9417,21,0.93 [0.32-2.69],0.8923332186529641
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,11019,27,0.43 [0.15-1.26],0.1240772905961459
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,11019,27,0.78 [0.27-2.23],0.6368593837148494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,9537,22,0.80 [0.24-2.68],0.7116868535259806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,11122,28,1.08 [0.55-2.11],0.8246873256101728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,10595,27,0.78 [0.25-2.49],0.6802066907978237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,11006,28,0.90 [0.15-5.36],0.905341769580218
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,11006,28,0.62 [0.18-2.08],0.4376774755057867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,9551,22,1.07 [0.47-2.42],0.8769028523658097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,9543,22,1.06 [0.17-6.37],0.95337007383371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,9230,19,0.92 [0.43-1.96],0.8267475752840595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,9230,19,1.56 [0.78-3.11],0.2104915333665221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,9515,22,1.36 [0.79-2.34],0.2690105259330836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,10741,27,1.13 [0.67-1.89],0.656930992625004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,11032,27,1.15 [0.77-1.71],0.5006903609539864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,9537,22,1.53 [1.06-2.20],0.0221447852012961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,10944,27,1.13 [0.61-2.10],0.699847957415279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,10662,28,0.90 [0.37-2.18],0.8177580969266087
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,11104,28,0.74 [0.42-1.29],0.2858355916624053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,11024,27,1.28 [0.81-2.03],0.2895217342792698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,11024,27,0.61 [0.24-1.60],0.3177520598256467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,9417,21,0.42 [0.08-2.29],0.3136139241533336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,9543,22,1.28 [0.30-5.39],0.7371107829029865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,11122,28,0.75 [0.28-2.00],0.5620850814091172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,9253,22,0.50 [0.17-1.46],0.2033667972705805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,11148,28,0.58 [0.18-1.85],0.3540249554780489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,11024,27,0.81 [0.32-2.01],0.6456993009076992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,10778,27,0.91 [0.39-2.11],0.8203491000769123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,10964,28,0.96 [0.58-1.59],0.8626330727565372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,11024,27,0.70 [0.31-1.57],0.3837325870435054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,9230,19,0.89 [0.26-3.04],0.8497467694500844
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,9549,22,1.26 [0.74-2.15],0.3860252801827639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,9253,22,0.97 [0.42-2.24],0.949572096382294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,10964,28,0.99 [0.73-1.35],0.9536333528498108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,10964,28,1.08 [0.75-1.55],0.6867063771577199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,10964,28,0.72 [0.24-2.13],0.5541958506854336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,11013,28,0.27 [0.08-0.92],0.036309503443253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,11122,28,0.77 [0.35-1.70],0.5169711335574175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,11016,27,0.36 [0.17-0.77],0.0086948720859994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,9537,22,1.25 [0.76-2.05],0.3775649988814267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,9417,21,0.53 [0.20-1.44],0.2134183519889272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,9537,22,1.43 [0.57-3.57],0.4489844201817917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,9417,21,1.40 [0.63-3.09],0.4070262970504836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,11019,27,1.15 [0.78-1.69],0.4744629109830405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,10741,27,0.73 [0.33-1.61],0.4380313815237543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,10592,27,0.78 [0.43-1.40],0.4034087250457533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,9577,22,0.43 [0.14-1.30],0.1344084450280175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,10812,26,0.86 [0.43-1.75],0.6808627702138983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,9288,20,1.00 [0.31-3.20],0.996092759927074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,10812,26,1.02 [0.41-2.58],0.959260071737716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,9577,22,1.21 [0.65-2.27],0.5523241791813398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,11125,28,1.29 [0.76-2.19],0.3514575121810561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,9354,21,2.17 [0.56-8.35],0.2603861532396598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,9288,20,0.60 [0.11-3.14],0.5457816071139361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,9253,22,1.05 [0.55-2.00],0.8867271408074329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,9417,21,0.73 [0.32-1.66],0.4576421445382621
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,9417,21,1.05 [0.58-1.92],0.8616298182451962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,9260,21,0.77 [0.24-2.49],0.6653606261496389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,9230,19,1.07 [0.39-2.93],0.8900295987634315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,10831,27,0.57 [0.24-1.34],0.1950377625517395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,9298,19,1.59 [1.01-2.49],0.0451542329065211
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,10741,27,1.20 [0.77-1.86],0.4263475927121981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,9417,21,1.00 [0.45-2.25],0.9969300842510492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,9230,19,2.30 [0.84-6.28],0.1046592042518982
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,10726,25,1.26 [0.76-2.07],0.3666800533133251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,10741,27,1.02 [0.61-1.70],0.9464106445388576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,10778,27,1.30 [0.75-2.27],0.3504637513519753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,11031,28,0.63 [0.41-0.97],0.0349041861314181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,10964,28,0.52 [0.26-1.03],0.0612478731606324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,10964,28,0.42 [0.23-0.78],0.0062429554152004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,10778,27,1.18 [0.73-1.89],0.5006170310916881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,9537,22,1.42 [0.88-2.29],0.1557251755003937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,9417,21,0.72 [0.20-2.57],0.6179718905370672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,10741,27,1.08 [0.55-2.12],0.8319432867487444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,9580,22,1.45 [0.24-8.67],0.6820906394482457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,9042,19,1.12 [0.17-7.52],0.9060918128797604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,9509,22,1.07 [0.51-2.23],0.8537394267750703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,9558,22,1.12 [0.62-2.02],0.7032027205424748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,9453,22,1.17 [0.42-3.25],0.7572666681464364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,9580,22,5.45 [0.76-39.32],0.0926693169317917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFP,Properdin,9580,22,0.96 [0.15-6.24],0.9673671584326764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,11006,28,1.32 [0.77-2.28],0.3132314152426492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,9572,22,0.56 [0.19-1.60],0.2770553165937667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,9317,19,1.15 [0.41-3.23],0.786681006367547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,11024,27,1.24 [0.57-2.70],0.5905331182741922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,10741,27,0.89 [0.49-1.64],0.7150258051455787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,9354,21,1.46 [0.58-3.69],0.4177501240998876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",9543,22,1.09 [0.43-2.80],0.8513800178188861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,9529,22,1.43 [0.40-5.03],0.5806610471610558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,10812,26,1.05 [0.35-3.09],0.9333389615109527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,9577,22,1.43 [0.99-2.08],0.0591339438088285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,11091,28,1.53 [0.69-3.44],0.2980266589322828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,10782,28,0.91 [0.59-1.39],0.6535938641122215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,11057,28,0.94 [0.78-1.14],0.5283589455883284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,11045,28,1.31 [0.44-3.93],0.6240304681877282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,9317,19,1.58 [0.88-2.84],0.1264429081845653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,10944,27,1.41 [0.90-2.21],0.1283008258732255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,9564,22,1.66 [0.83-3.33],0.1543785672576544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,9253,22,1.06 [0.62-1.81],0.8358867540274406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,11038,28,0.45 [0.17-1.19],0.1081561565696938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,11024,27,0.64 [0.31-1.32],0.2248673268355402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,9317,19,1.24 [0.42-3.62],0.6968889235463678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,11032,27,1.21 [0.70-2.10],0.494363652016649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,9577,22,0.98 [0.47-2.05],0.9555679190746632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,9417,21,0.80 [0.27-2.41],0.6933948923810537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,9537,22,1.68 [1.08-2.61],0.0216204030942371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,9317,19,0.70 [0.24-1.99],0.5027530702681637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,11100,28,0.80 [0.21-3.01],0.7389540584258085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,9577,22,1.14 [0.56-2.34],0.715140450270435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",10958,28,1.02 [0.60-1.73],0.9449378134588962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,9230,19,0.66 [0.31-1.40],0.2742477375741734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,11007,27,0.92 [0.55-1.53],0.7486552357972553
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,10944,27,0.60 [0.24-1.54],0.287823178192471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,10988,28,0.88 [0.43-1.78],0.7137429893664287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,9288,20,1.54 [0.29-8.22],0.6124904167184253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,11006,28,0.70 [0.22-2.19],0.5355975461412732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,10812,26,0.57 [0.19-1.69],0.3130556702388034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,11122,28,0.99 [0.70-1.40],0.9545769030369656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,9317,19,0.75 [0.26-2.15],0.5891313272982389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,9371,21,0.84 [0.11-6.53],0.8657652063661836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,11019,27,0.95 [0.37-2.46],0.915788126541296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,11019,27,1.62 [0.84-3.15],0.1523728164658467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,11019,27,0.91 [0.53-1.58],0.7444992632300078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,11019,27,0.87 [0.32-2.38],0.7900364147080783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,9568,22,0.92 [0.41-2.10],0.849224656605547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,10984,27,1.87 [0.66-5.31],0.2424331411129777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,10741,27,0.92 [0.44-1.92],0.8246177506770784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,11159,28,1.17 [0.61-2.26],0.6369167590050868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,9317,19,1.40 [0.55-3.54],0.4769671664933842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,9317,19,1.21 [0.42-3.48],0.7255862370435688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,9230,19,0.75 [0.26-2.19],0.598088323568128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,11019,27,1.04 [0.77-1.41],0.7832438493058519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,11112,28,1.60 [0.34-7.53],0.554086419982882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,9317,19,0.21 [0.04-0.98],0.0474646466704771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",10926,27,1.16 [0.82-1.64],0.4090266897079074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,10989,28,1.21 [0.77-1.91],0.3999078234660684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,10760,27,1.17 [0.55-2.48],0.6816614235691157
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,10778,27,0.80 [0.38-1.70],0.5596743386975425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,11159,28,1.15 [0.53-2.52],0.7212303642779205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,9543,22,0.85 [0.21-3.41],0.8170618541654223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,10812,26,0.75 [0.33-1.70],0.4858329592195197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,9580,22,1.04 [0.23-4.62],0.9586930211175344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,11001,27,0.59 [0.27-1.27],0.176629327294234
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,9564,22,1.57 [1.03-2.41],0.0379934780464835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,9529,22,1.57 [0.98-2.52],0.063234005385807
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,11063,28,1.68 [0.75-3.76],0.2091611758412173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,9253,22,0.65 [0.23-1.86],0.424247457132877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",9283,18,1.87 [1.08-3.26],0.0266564886826027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,10812,26,1.55 [1.08-2.24],0.0181156317198444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,10964,28,1.07 [0.69-1.66],0.7464196749586952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNST,Consortin,11024,27,1.09 [0.79-1.49],0.5973065316944288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,9253,22,0.98 [0.28-3.46],0.9755473196637848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,11148,28,0.55 [0.15-1.99],0.3605092796989145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,11112,28,0.99 [0.47-2.10],0.9780311081036503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,11006,28,0.84 [0.27-2.60],0.7555060659667114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,11006,28,1.15 [0.27-5.00],0.8500731990125304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,11051,28,1.10 [0.43-2.84],0.8427390350006467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,11019,27,0.69 [0.31-1.58],0.3835144854464122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,9317,19,0.86 [0.51-1.44],0.563284302324903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,9564,22,1.68 [0.76-3.69],0.1988474469042981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,9577,22,1.40 [0.33-5.95],0.6495039023782683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,11044,28,0.74 [0.17-3.27],0.6940730568563813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,11148,28,2.66 [0.67-10.54],0.1647495929953579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,9537,22,1.62 [0.75-3.50],0.2218937825616933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,9317,19,1.04 [0.61-1.75],0.8909058410025805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,9298,19,1.38 [0.81-2.34],0.2400323650195477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,9577,22,2.77 [0.56-13.74],0.2137369103505551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,11024,27,0.74 [0.30-1.84],0.5178349636749273
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,9399,21,0.72 [0.36-1.44],0.3499108068105759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,9354,21,1.33 [0.48-3.67],0.5812903122212874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,11148,28,1.27 [0.48-3.39],0.627519727140117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,11019,27,1.28 [0.62-2.64],0.5027219929280098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,9417,21,0.43 [0.13-1.45],0.1718492529009261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,10994,28,0.98 [0.26-3.65],0.9752657231436608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,9298,19,2.10 [1.12-3.95],0.0214699933532929
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,9529,22,1.31 [0.48-3.56],0.5932383784659714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,10909,28,2.14 [0.80-5.74],0.1304033670152111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,10687,26,1.17 [0.77-1.78],0.4672055184634263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',9260,21,1.05 [0.39-2.83],0.9270175984575664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,10778,27,0.96 [0.43-2.15],0.9154678730114718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",9298,19,1.33 [0.57-3.10],0.5084501805279518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,10797,27,0.97 [0.66-1.42],0.8646638374156492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,9253,22,0.95 [0.32-2.81],0.9258198609358927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",10964,28,0.97 [0.60-1.57],0.8999588934984144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,9564,22,1.66 [0.52-5.30],0.3909246257343202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,11148,28,1.22 [0.74-2.00],0.4328017267990426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,11085,27,1.38 [0.86-2.21],0.182411286865981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,9179,20,0.83 [0.32-2.19],0.7061364894047042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,11148,28,1.45 [0.89-2.35],0.1316625141827873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,9565,22,6.76 [1.31-34.93],0.022475642284416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,11021,27,1.29 [0.51-3.26],0.5939714612143395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,9230,19,1.11 [0.30-4.08],0.8713843122453715
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,11077,28,0.89 [0.34-2.33],0.8179286370375083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",9288,20,3.38 [1.32-8.67],0.0113714101634437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,11122,28,1.20 [0.74-1.95],0.4529466721825899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,9561,22,1.18 [0.37-3.74],0.7729524362670086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,9260,21,1.78 [0.82-3.85],0.1466505695080863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,11089,28,0.73 [0.34-1.59],0.4321766337393167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,11032,27,0.84 [0.51-1.38],0.4966501545708265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,9564,22,2.01 [0.49-8.16],0.3290413963660259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,9538,22,0.72 [0.22-2.36],0.5845650750065031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,11063,28,1.58 [0.77-3.23],0.210702871010598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,10741,27,1.05 [0.71-1.54],0.8034574395855434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,10926,27,1.30 [0.82-2.07],0.2630453619099113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,9230,19,0.57 [0.21-1.57],0.2776779426645228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,9230,19,0.97 [0.17-5.35],0.9676836599160252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,10854,26,0.42 [0.19-0.94],0.0344050243607752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,9354,21,2.33 [0.78-6.93],0.1295375676417094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,11038,28,1.05 [0.56-1.98],0.8772194371691494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,10724,27,1.03 [0.69-1.53],0.8939838201281555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,10994,28,1.03 [0.30-3.54],0.96054960385012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,10812,26,1.27 [0.83-1.95],0.2687473332697419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,11052,28,1.06 [0.20-5.65],0.9438272506649128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,10944,27,0.44 [0.16-1.23],0.1162786394849677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,11112,28,1.13 [0.59-2.17],0.7094259275422883
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,9480,22,0.49 [0.11-2.26],0.3612062442885535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,11015,28,1.08 [0.78-1.49],0.6301984462271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,11052,28,0.61 [0.16-2.30],0.4616112499517273
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,10694,27,1.66 [1.02-2.69],0.0406626766439053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,11148,28,4.71 [1.43-15.52],0.010848671594917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,10944,27,0.96 [0.48-1.90],0.896759737436551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,9317,19,0.70 [0.24-2.06],0.5148667032046284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,10812,26,1.05 [0.77-1.43],0.7561868492703026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,9564,22,1.57 [0.89-2.79],0.1217503266737975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,9543,22,0.90 [0.46-1.74],0.747198889857513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,9543,22,0.81 [0.53-1.23],0.3225250102570033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,9253,22,1.05 [0.61-1.81],0.8656419812957067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,9298,19,1.85 [1.13-3.01],0.0142674794125284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,9260,21,1.14 [0.85-1.53],0.3848587775887737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,11052,28,0.97 [0.27-3.56],0.9690482232951728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,9572,22,1.06 [0.40-2.80],0.9125263762787286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,9260,21,1.38 [0.50-3.82],0.5376014542684822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,10944,27,0.82 [0.46-1.45],0.4891549649144627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,9288,20,1.89 [0.77-4.69],0.1667222628601905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,10831,27,0.88 [0.43-1.82],0.7322580413284338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,9288,20,0.89 [0.22-3.57],0.8653646052827093
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,9572,22,0.81 [0.19-3.41],0.7705996972645299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,9288,20,1.46 [0.85-2.50],0.1729651912704644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,9549,22,2.68 [1.16-6.18],0.020465594829609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,9577,22,3.60 [1.18-11.05],0.0249184088661264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,9253,22,1.63 [0.88-3.02],0.1195022095290246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,9260,21,0.94 [0.60-1.48],0.7987250369940254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,8296,17,1.27 [0.80-2.03],0.3127106839956645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,11041,28,0.92 [0.26-3.21],0.8937324460117679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,10796,27,1.07 [0.58-2.00],0.8207492145916645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,10736,26,1.11 [0.54-2.31],0.7705861248123499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,11014,28,1.02 [0.72-1.43],0.9237799401382072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,10866,27,1.66 [0.83-3.34],0.1551629659979585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,9397,21,0.45 [0.18-1.13],0.0904478207197574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,9449,22,0.42 [0.14-1.30],0.1330565008101706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,10812,26,1.13 [0.75-1.68],0.5584470019231051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,9577,22,1.81 [0.43-7.58],0.4175727446307092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,9577,22,1.56 [0.75-3.25],0.2379057777221394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,9253,22,0.77 [0.20-3.00],0.7113509274993969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,11006,28,1.31 [0.74-2.31],0.358760540695158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,10995,28,1.07 [0.64-1.78],0.8094974830398332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,9543,22,1.49 [0.86-2.59],0.155211921525766
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,11008,28,0.99 [0.50-1.94],0.9723519038676232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,10970,28,0.88 [0.42-1.85],0.7263444766148331
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,10310,26,0.73 [0.27-1.92],0.5179249976338098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,9354,21,1.19 [0.54-2.59],0.6679890965019633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,11032,27,0.56 [0.24-1.30],0.1766724997480522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,10784,26,1.34 [0.84-2.14],0.2132011668420005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,11024,27,0.72 [0.17-3.12],0.661239652532763
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,11159,28,0.96 [0.33-2.83],0.9439084620201942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,8709,24,0.23 [0.04-1.29],0.0944862168738812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,11070,27,0.55 [0.22-1.38],0.202046097001121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,11028,27,0.68 [0.23-2.04],0.4971943282355615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,9317,19,1.07 [0.39-2.94],0.8967160997028698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,9484,22,0.85 [0.40-1.77],0.6601706346657193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,10944,27,0.95 [0.33-2.76],0.9240409981011872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,11019,27,0.98 [0.48-2.00],0.9656034494351086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,10982,28,1.00 [0.70-1.44],0.9926561948938016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,11052,28,0.88 [0.50-1.54],0.6603698778759977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,11122,28,1.05 [0.68-1.61],0.83860163638407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,10831,27,0.90 [0.38-2.11],0.8059308317487296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,11122,28,0.63 [0.31-1.29],0.2092352226725814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,10831,27,0.57 [0.26-1.25],0.1632572194405644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,11128,28,1.32 [0.31-5.65],0.7090853131613831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,11159,28,0.55 [0.25-1.22],0.1413215615428078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,11000,28,1.09 [0.76-1.55],0.6352848776415139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,10986,27,1.13 [0.84-1.53],0.4263557836949937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,11159,28,0.91 [0.58-1.42],0.6738900716814791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,10934,27,1.01 [0.62-1.67],0.9537420247291758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,11052,28,1.00 [0.59-1.68],0.98653046820344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,9230,19,1.58 [1.12-2.23],0.0093851696289205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,9432,22,1.18 [0.59-2.36],0.6485197419497855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",9260,21,0.97 [0.57-1.67],0.9221404478241664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,9230,19,0.47 [0.21-1.06],0.0698235457509612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,9577,22,0.40 [0.08-2.09],0.2786191558958341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,9354,21,1.54 [0.95-2.51],0.0805497974079215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,11112,28,1.13 [0.84-1.53],0.4116408888036725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,11052,28,0.90 [0.45-1.79],0.7555232719383799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,9288,20,0.63 [0.38-1.06],0.0819090951615174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,9288,20,1.39 [0.80-2.40],0.2394358335296469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,11019,27,1.19 [0.87-1.63],0.2748411931447826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",10926,27,1.32 [0.81-2.15],0.2710975300746752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,9559,22,0.70 [0.55-0.88],0.0030361159339515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,10952,28,1.23 [0.82-1.86],0.320399613181578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,9288,20,1.48 [0.75-2.95],0.2618889513875664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,11052,28,1.05 [0.73-1.51],0.775981340083904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",11032,27,0.60 [0.25-1.44],0.2556328059959428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,9317,19,0.17 [0.01-2.07],0.1652592574826871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,9230,19,0.82 [0.37-1.83],0.6283703158468573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,9230,19,0.73 [0.16-3.26],0.6761408807174853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCN,Decorin,10812,26,0.80 [0.15-4.22],0.7911630397448528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,9354,21,1.65 [1.04-2.63],0.0345072275716411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,11112,28,1.02 [0.60-1.71],0.9475482080666486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,10964,28,0.86 [0.59-1.24],0.4171864455383138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,10778,27,0.91 [0.55-1.51],0.707241358524655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,11024,27,1.08 [0.36-3.24],0.8865758953033986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,9253,22,0.89 [0.49-1.63],0.7099321382650848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,9230,19,1.24 [0.78-1.96],0.3605116389505145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,11032,27,0.60 [0.31-1.16],0.130845183226026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,9260,21,0.90 [0.29-2.82],0.8540349410017688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",10964,28,1.12 [0.54-2.34],0.7537144543456601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,11014,27,1.42 [0.71-2.84],0.320893885845932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,9549,22,1.73 [0.94-3.18],0.0768750874275817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,9354,21,1.02 [0.59-1.77],0.9420378466063706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,11122,28,0.27 [0.06-1.25],0.0951973463390483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,9577,22,1.05 [0.40-2.75],0.9247690392243024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,9537,22,0.80 [0.32-2.00],0.6277424250543673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,9317,19,0.51 [0.11-2.33],0.3831016758390259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,9288,20,0.83 [0.12-5.83],0.8475488823775349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,9288,20,1.34 [0.79-2.25],0.2750075171365408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,9317,19,0.46 [0.13-1.69],0.2435406657796422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,10741,27,0.86 [0.45-1.65],0.6441123349082596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",11019,27,1.13 [0.79-1.62],0.4906445883429643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,10808,27,1.35 [0.78-2.34],0.284751080993461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,9227,20,1.00 [0.34-2.89],0.9951103957003412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,9253,22,0.70 [0.30-1.63],0.4060437896147051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,9253,22,1.31 [0.86-1.97],0.204512997955661
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,9253,22,0.35 [0.09-1.26],0.1074342523011757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,10836,28,0.91 [0.72-1.16],0.4522368854883803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,9260,21,0.91 [0.36-2.34],0.846218208760789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,9288,20,1.17 [0.57-2.40],0.6611828589155385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,11159,28,1.01 [0.62-1.67],0.9571083330005496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,9253,22,0.51 [0.15-1.76],0.2849941886421248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,9288,20,1.55 [0.74-3.25],0.2442720411128895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,10831,27,0.84 [0.32-2.23],0.724984104486483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,9260,21,0.95 [0.36-2.52],0.9175226198209286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,9529,22,1.31 [0.50-3.47],0.586066814997412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,9543,22,1.29 [0.61-2.70],0.5053798300567598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",10984,27,1.08 [0.79-1.47],0.6381278289448578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,9317,19,1.09 [0.38-3.12],0.8713058879491475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,9354,21,1.46 [0.44-4.82],0.5390373710964962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,11122,28,0.79 [0.46-1.37],0.4003564381963121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,11148,28,1.00 [0.31-3.17],0.9942162577174803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,10924,27,0.78 [0.35-1.71],0.53178443134051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,10964,28,1.01 [0.68-1.51],0.958394222827355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,9543,22,1.40 [0.85-2.32],0.1875778014364419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,9549,22,1.45 [0.88-2.39],0.1463147260369661
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,11148,28,0.70 [0.39-1.24],0.2197995711291916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,11032,27,1.61 [0.51-5.08],0.415599292449194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,9298,19,0.90 [0.46-1.75],0.7525830250996496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,9298,19,1.76 [0.98-3.18],0.0586770896604443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,9298,19,3.04 [1.41-6.57],0.0046941662479229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,9230,19,0.43 [0.12-1.54],0.1967912269773255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,11121,28,1.21 [0.80-1.82],0.3737651909805495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,9543,22,0.89 [0.50-1.58],0.6832460261094173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,10964,28,0.98 [0.66-1.45],0.9277862585762716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,9537,22,1.46 [0.83-2.56],0.1895144984511967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,9354,21,1.57 [0.75-3.28],0.2283139932688652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,9273,21,1.69 [1.04-2.74],0.0338488428638912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,10812,26,1.37 [0.86-2.17],0.1826481631874098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,9543,22,1.66 [0.81-3.38],0.1669447807500504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,9298,19,2.00 [1.24-3.24],0.0045466926535448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,9537,22,1.41 [0.83-2.37],0.2028829128829057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,10979,28,0.85 [0.24-3.04],0.799590511482787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,9253,22,1.16 [0.75-1.78],0.5041348175552287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,9537,22,1.56 [1.06-2.30],0.0233998460326537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,9549,22,2.18 [1.28-3.69],0.0039693640795007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,10944,27,0.93 [0.53-1.65],0.8051503247009529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,9543,22,1.44 [0.71-2.94],0.3110838474727978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,11029,28,0.79 [0.40-1.55],0.4883157976113332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,9317,19,0.93 [0.25-3.48],0.9128963817865244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,9253,22,1.04 [0.73-1.46],0.8341132302641319
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,9543,22,1.34 [0.96-1.87],0.0819623186290342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,11024,27,1.04 [0.79-1.37],0.7759532034374699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,10926,27,1.10 [0.51-2.35],0.8080064670967221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,10964,28,0.63 [0.20-2.03],0.4376642291205248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,11019,27,0.97 [0.38-2.49],0.9521877564710942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,10813,27,0.66 [0.19-2.27],0.5072288307405886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,10964,28,1.09 [0.40-2.95],0.8609540687892278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,10934,26,1.16 [0.67-2.00],0.5938721183970631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,11148,28,1.54 [0.39-5.99],0.5361260807026762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,11087,28,1.16 [0.70-1.92],0.5674934997495685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,10944,27,1.69 [0.76-3.76],0.1966608039129455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,10964,28,0.97 [0.54-1.74],0.9190020689674304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,10857,27,1.99 [0.76-5.21],0.1606782811619512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,9549,22,1.24 [0.40-3.83],0.7078754871286703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,11006,28,1.35 [0.39-4.69],0.6378904042474698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,11080,28,1.16 [0.45-3.02],0.7555927583172726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,10928,28,0.93 [0.47-1.88],0.8483981917721373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,9354,21,1.54 [0.97-2.46],0.0680435181100385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,9507,22,1.60 [0.78-3.25],0.1972164900266572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,9317,19,0.97 [0.45-2.11],0.9437745292074422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,10964,28,0.23 [0.05-1.07],0.0604342241241463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,9564,22,1.67 [0.94-2.97],0.0832031368551968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,10812,26,1.00 [0.61-1.64],0.9916724045594296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,9529,22,1.22 [0.49-3.00],0.6674143183564235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,9317,19,0.96 [0.48-1.91],0.9067159415633036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,10778,27,0.98 [0.65-1.48],0.9336771186951324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",9537,22,1.49 [1.01-2.20],0.0422719056309534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,9543,22,1.32 [0.54-3.20],0.5422031385403021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,9529,22,1.34 [0.71-2.52],0.3612969494879482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,9317,19,1.25 [0.78-2.00],0.3613657244851512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,9529,22,1.99 [0.85-4.65],0.1116936955346141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,10944,27,1.15 [0.80-1.64],0.4513628834009161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,11101,28,0.72 [0.23-2.24],0.5724922781697245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,10778,27,0.54 [0.21-1.42],0.2131301945908169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",9564,22,0.99 [0.58-1.70],0.9733916107514496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",9298,19,1.39 [0.90-2.14],0.1352740030257801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,9260,21,1.16 [0.61-2.18],0.6517154847889507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,9324,21,1.64 [0.53-5.11],0.389783195319986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,9253,22,0.98 [0.43-2.22],0.9528567606225764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,11112,28,1.24 [0.51-2.97],0.6372634019024054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,11019,27,1.22 [0.85-1.75],0.279233550617497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,9529,22,0.51 [0.24-1.10],0.0841517886358689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,9260,21,0.64 [0.16-2.58],0.5349419884955677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,9549,22,1.37 [0.92-2.05],0.1248858071523962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,10812,26,1.30 [0.53-3.19],0.5680710381154377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,9298,19,1.51 [0.36-6.37],0.5768197819878279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,9288,20,1.31 [0.61-2.82],0.482206216663305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,9564,22,1.37 [0.90-2.07],0.1406674110281779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,9537,22,1.46 [0.41-5.17],0.5587156582615587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,9417,21,1.74 [0.65-4.64],0.2712299250426452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,11044,28,1.26 [0.44-3.59],0.671553252270936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,9549,22,1.08 [0.36-3.20],0.8903546217950882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,10985,28,0.70 [0.19-2.53],0.5876143128126385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,10924,27,0.99 [0.29-3.39],0.9904169438359252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,9317,19,0.84 [0.36-1.95],0.6856153457904038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,10979,28,1.03 [0.75-1.42],0.8570428762889399
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,10741,27,0.75 [0.30-1.87],0.538833614504739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,9537,22,0.93 [0.25-3.51],0.9187647025118492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,11148,28,2.71 [0.33-22.38],0.3551358055110345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,11019,27,1.02 [0.55-1.88],0.944197782452336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,9564,22,1.54 [0.93-2.56],0.0922477685919876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,9298,19,1.49 [1.00-2.21],0.0514838971466149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",9543,22,0.94 [0.45-1.96],0.8638921240834846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",9506,22,1.27 [0.90-1.80],0.1776913642400691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,9260,21,1.12 [0.61-2.06],0.7098903949169819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,9298,19,0.96 [0.34-2.70],0.9419672495216864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,10944,27,1.02 [0.55-1.92],0.9397046307040486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,9288,20,1.61 [1.01-2.58],0.0475741479251505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,11024,27,0.92 [0.53-1.58],0.7547773863939908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,11159,28,1.18 [0.83-1.67],0.3498900449778128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,9549,22,1.27 [0.72-2.23],0.4130798189442259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,9260,21,1.55 [0.80-2.99],0.1944572588770398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,10831,27,0.71 [0.21-2.36],0.5719100674925689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,9549,22,1.68 [1.04-2.73],0.0347850542003507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,9253,22,1.12 [0.70-1.79],0.6384348837197446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELN,Elastin,9564,22,1.19 [0.38-3.77],0.7631545353363165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,10964,28,0.96 [0.52-1.79],0.9033123633853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,9260,21,1.45 [0.55-3.84],0.4539779365024308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,10831,27,1.71 [0.94-3.11],0.0814444575343603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,8832,22,0.82 [0.38-1.75],0.6106271440939954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,11148,28,0.43 [0.06-3.13],0.4081627885705576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,11018,27,1.20 [0.78-1.87],0.4101291190659751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,11122,28,1.29 [0.78-2.14],0.3127928550617997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,9298,19,1.05 [0.53-2.05],0.8968331434252893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,9529,22,1.07 [0.52-2.21],0.8450126582057161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,9260,21,2.05 [0.56-7.51],0.2803033439545775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,9260,21,0.60 [0.15-2.35],0.4652133398898141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,11148,28,1.19 [0.30-4.68],0.8060984281821632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,11052,28,0.68 [0.40-1.16],0.1549638099783146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,9298,19,0.64 [0.19-2.17],0.4792563800674753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,10687,27,1.15 [0.76-1.73],0.5088832881397056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,9529,22,1.51 [0.79-2.86],0.2098294227652809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,10741,27,0.89 [0.40-1.95],0.767660690592874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,10812,26,2.16 [0.41-11.29],0.359789153039403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,10812,26,0.49 [0.17-1.42],0.1886562709615284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,9298,19,0.83 [0.39-1.80],0.6419350471587387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,9288,20,1.74 [0.80-3.76],0.161877179891152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,9317,19,0.36 [0.14-0.96],0.0411411148199576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,10995,28,1.12 [0.79-1.60],0.5213628317467125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,9529,22,0.29 [0.05-1.74],0.1762207968721931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,11029,28,0.40 [0.16-1.02],0.0549642077298582
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,10778,27,1.11 [0.70-1.78],0.6512439053051937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,10621,27,1.09 [0.34-3.48],0.8878689349820255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,9354,21,3.10 [0.78-12.30],0.1072269759520987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,11148,28,0.51 [0.12-2.21],0.3718137407128743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,10926,27,1.61 [0.53-4.83],0.3998692520512665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,10812,26,1.11 [0.65-1.89],0.6978862765187905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,9417,21,1.11 [0.43-2.89],0.8239593550155988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,11019,27,0.65 [0.37-1.16],0.1428631732781902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,9298,19,1.17 [0.67-2.05],0.5713386477776592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,11098,28,1.08 [0.35-3.29],0.8912422802934368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,11032,27,0.44 [0.16-1.22],0.1136076825571845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,10952,28,1.81 [0.34-9.66],0.4850239747380054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,11032,27,2.34 [0.58-9.51],0.2327994881080856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,10964,28,1.06 [0.77-1.47],0.7127808524045225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,9317,19,1.26 [0.80-1.99],0.3163650689450096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,9230,19,0.55 [0.12-2.55],0.4458223017430173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,10926,27,1.10 [0.74-1.66],0.6332441727898135
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,9417,21,0.39 [0.10-1.55],0.1797761677255687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,9288,20,0.88 [0.33-2.36],0.8044348946099884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,9529,22,0.54 [0.18-1.64],0.2777387172488329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,9354,21,1.58 [1.09-2.28],0.0145280874987409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,10949,28,0.40 [0.11-1.45],0.1618604840178328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,9260,21,0.49 [0.15-1.57],0.2287814010638574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,11148,28,0.57 [0.19-1.70],0.3152033533834518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,10994,28,0.83 [0.31-2.22],0.707438964566447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,9230,19,1.11 [0.51-2.39],0.7983134361233429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,9288,20,0.75 [0.30-1.87],0.5388657126228972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,9543,22,1.62 [1.04-2.53],0.031389261446326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,9230,19,1.17 [0.46-3.00],0.7416608131469987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,9288,20,1.48 [0.93-2.34],0.0974432178378722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,9417,21,0.79 [0.19-3.24],0.7455024427648774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,9260,21,0.66 [0.25-1.75],0.399462389257936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,9260,21,0.98 [0.39-2.48],0.9726310607738134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,11122,28,0.28 [0.07-1.20],0.0872220544018476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,9572,22,1.56 [0.59-4.09],0.3683797160767184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,9442,22,1.19 [0.39-3.65],0.7574895491980278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,11006,28,0.91 [0.50-1.65],0.7534192740363924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,9580,22,0.51 [0.21-1.27],0.1485004537790439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,9537,22,1.58 [0.33-7.61],0.568442799774596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,9580,22,6.67 [0.68-65.47],0.1032735700396944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,11038,28,0.97 [0.55-1.71],0.906168993252742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,11042,28,1.46 [0.41-5.18],0.5569824544409384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,11043,28,1.22 [0.39-3.77],0.7321623197148577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,11052,28,0.76 [0.12-4.62],0.762312790880898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",10994,28,0.87 [0.60-1.27],0.4813461651330144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",11024,27,1.26 [0.83-1.91],0.274973769219512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",9564,22,1.38 [0.76-2.50],0.2929292158191773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",11148,28,1.68 [0.96-2.95],0.0694052241271262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,11091,28,1.05 [0.64-1.73],0.836019499364949
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,10796,26,1.87 [1.17-3.01],0.0092234076555021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,11019,27,0.50 [0.26-0.95],0.0341935859390914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,11024,27,1.19 [0.77-1.84],0.4333053358769736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,9537,22,1.43 [0.83-2.46],0.2008435935910203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,9549,22,0.88 [0.65-1.19],0.4045570259216938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,9529,22,0.75 [0.15-3.88],0.7363599828096756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,9298,19,2.64 [1.38-5.04],0.0032129331030697
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,9564,22,0.44 [0.10-1.92],0.2725943851060077
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,10964,28,1.03 [0.39-2.67],0.9563718751437504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,11014,27,1.39 [0.44-4.40],0.577004615162902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,9537,22,1.04 [0.65-1.66],0.884426265781973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,11148,28,1.15 [0.34-3.91],0.8256140951988054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,9317,19,1.13 [0.62-2.06],0.6841520839807969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,11108,28,0.87 [0.29-2.56],0.7946825294840545
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,11159,28,1.17 [0.48-2.84],0.7331012629692736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,9577,22,1.27 [0.35-4.60],0.7160175632194742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,9317,19,0.91 [0.42-1.98],0.8194027888016608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",11024,27,0.76 [0.47-1.24],0.2755839740483852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,9564,22,0.89 [0.49-1.60],0.7002005490615677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,11019,27,1.05 [0.51-2.15],0.8963208647087745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,9549,22,0.76 [0.14-4.11],0.7495319218003511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,11006,28,1.01 [0.50-2.02],0.9764364237444731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,10974,28,0.74 [0.48-1.15],0.1842001201918121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,10741,27,0.99 [0.55-1.78],0.9668889816329842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,11027,28,0.92 [0.47-1.81],0.8052030127110148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,9559,22,1.25 [0.57-2.76],0.5806827487626365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,10971,28,1.24 [0.52-2.94],0.6254240599900228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,11024,27,0.71 [0.32-1.59],0.4085251199704344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,11115,28,0.59 [0.28-1.25],0.1708977535722049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,10831,27,0.66 [0.34-1.30],0.2299751995722231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,11006,28,1.20 [0.67-2.13],0.5381491275384573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,11019,27,0.86 [0.52-1.41],0.5494201981090385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,10741,27,0.64 [0.32-1.28],0.2102748090537475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",9260,21,1.42 [0.93-2.17],0.1051757498610815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",9260,21,1.65 [0.96-2.85],0.0724319111327453
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,10741,27,1.13 [0.73-1.75],0.5792666007779693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,10741,27,0.88 [0.42-1.87],0.7472488143987438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,11052,28,0.89 [0.32-2.47],0.8264116844471384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,9366,21,1.80 [0.48-6.82],0.3853291654723079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",9549,22,1.56 [0.97-2.51],0.0677845513429278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,9288,20,0.68 [0.17-2.68],0.5769721299769094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,9288,20,1.53 [0.81-2.89],0.1856025387853078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,11052,28,0.82 [0.54-1.25],0.3562923880302943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,11019,27,0.73 [0.43-1.24],0.2432732701586002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,9288,20,0.76 [0.24-2.44],0.6442597044625942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,11101,28,0.79 [0.59-1.05],0.1060796337786702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,11093,28,0.59 [0.25-1.39],0.2281992213661965
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,9288,20,0.48 [0.08-3.04],0.4382825257670952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,10831,27,0.83 [0.30-2.28],0.7200403609692613
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,9288,20,1.38 [0.65-2.91],0.4008618343155954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,9230,19,0.92 [0.51-1.67],0.786771429166419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,9210,19,0.74 [0.24-2.24],0.5897598872810375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,11032,27,0.80 [0.29-2.23],0.6693314234576064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,9577,22,1.50 [0.69-3.27],0.3085662550667791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,9543,22,1.36 [0.46-3.98],0.5763719989195575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,11032,27,0.28 [0.09-0.92],0.0354769136834787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,9354,21,1.30 [0.59-2.89],0.5133241524259224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,9572,22,1.19 [0.62-2.27],0.6001891981396523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,10778,27,1.05 [0.61-1.80],0.8583283848959149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",9253,22,0.63 [0.30-1.33],0.2250986651599223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,9260,21,0.48 [0.17-1.37],0.1703997176895888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,10778,27,1.22 [0.75-1.99],0.4317514251066005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,10991,28,1.07 [0.70-1.64],0.7672956871759826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,9549,22,1.37 [0.92-2.06],0.1235241263302362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,11073,28,1.03 [0.78-1.38],0.8224819033742414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,10944,27,1.50 [0.67-3.35],0.3196238538067745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,10944,27,1.18 [0.82-1.71],0.3697283014078056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,10760,27,1.06 [0.52-2.18],0.8730841036668809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,9537,22,1.86 [0.99-3.51],0.0552059057449954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,10741,27,1.12 [0.83-1.50],0.4736077110045431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,10944,27,1.39 [0.44-4.39],0.5759217123993565
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,10951,28,0.20 [0.04-1.07],0.0598391045636853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,10741,27,1.97 [0.90-4.27],0.0879434113163578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,11159,28,0.46 [0.20-1.07],0.0715953858074767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,11032,27,1.81 [0.64-5.08],0.2603925904456589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,10778,27,0.76 [0.40-1.44],0.3965445270527149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,10741,27,2.03 [0.85-4.85],0.1092945290428267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,9580,22,0.37 [0.08-1.78],0.2154288201985865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,9543,22,1.05 [0.44-2.49],0.9099251424922896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,9529,22,1.77 [0.80-3.90],0.1588494724408381
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,9288,20,1.03 [0.70-1.50],0.8932561117022724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,10983,27,0.86 [0.25-2.92],0.8085069820634967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,11122,28,1.17 [0.37-3.67],0.7892350425468223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,10999,27,0.63 [0.38-1.05],0.0748179710506907
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,9210,19,0.63 [0.18-2.20],0.4727132073983925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,10778,27,1.20 [0.55-2.62],0.6436848053535169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,9288,20,1.98 [1.08-3.64],0.0272302715139129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,11019,27,0.98 [0.66-1.46],0.9383042002472708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,10741,27,0.92 [0.64-1.32],0.6395724703804992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,9260,21,1.23 [0.71-2.14],0.4571810117366918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,9317,19,1.15 [0.34-3.89],0.82693286989804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,10913,27,0.81 [0.22-3.00],0.7469313426865678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,9298,19,1.17 [0.47-2.96],0.7332723590438834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FST,Follistatin,11038,28,0.80 [0.40-1.62],0.5327453821932796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,9298,19,5.25 [1.08-25.59],0.0400934674909674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,10980,28,0.83 [0.27-2.53],0.7398932684781834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,9521,22,0.49 [0.28-0.86],0.0132580228712838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,11065,28,1.03 [0.68-1.56],0.8781845829322348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,9354,21,0.78 [0.40-1.53],0.4681116519513174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FURIN,Furin,11032,27,0.87 [0.32-2.37],0.7850242211140432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,10722,27,0.84 [0.34-2.07],0.7099809672683983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",9404,21,0.99 [0.48-2.01],0.9678451536080552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,11122,28,1.29 [0.62-2.68],0.4979845830183843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",10944,27,0.97 [0.53-1.75],0.914299645290516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",11112,28,1.15 [0.73-1.81],0.550499401445468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,10831,27,1.03 [0.61-1.75],0.9032603985978253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,10989,28,1.05 [0.73-1.50],0.793653747653441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,9317,19,0.63 [0.23-1.75],0.3760802772722035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,9253,22,1.52 [0.73-3.19],0.2627555375679983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,9529,22,1.41 [0.70-2.84],0.3296510079939206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,9417,21,1.11 [0.65-1.89],0.7032639932763408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,9253,22,1.00 [0.55-1.83],0.995851269994087
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,9230,19,1.00 [0.19-5.43],0.9970487985188938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,9288,20,0.85 [0.28-2.53],0.7674998788723969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,9417,21,1.43 [0.89-2.30],0.1400352264479158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,9298,19,2.82 [1.50-5.31],0.0012478623900401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,9230,19,1.48 [0.87-2.52],0.1470632382896038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,11052,28,1.11 [0.67-1.83],0.6876157816561852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,10964,28,0.68 [0.20-2.26],0.5258573650052403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,11112,28,0.94 [0.26-3.31],0.918312577846811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,10831,27,1.59 [0.73-3.48],0.2441531237434075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,9564,22,0.53 [0.13-2.25],0.3892964834318557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,10964,28,0.30 [0.07-1.33],0.113262264756422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,9260,21,0.59 [0.13-2.59],0.4810000289737565
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,9162,20,2.85 [0.52-15.58],0.2273911060610974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,9549,22,1.84 [0.58-5.85],0.3003264404323761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,9417,21,1.02 [0.46-2.25],0.9693058899117876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,11070,28,0.58 [0.15-2.19],0.4193371434878868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,9260,21,2.15 [0.91-5.09],0.0815017020780979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,9543,22,1.07 [0.78-1.47],0.6698224936761547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,9230,19,1.41 [0.27-7.40],0.6875036656572455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",9298,19,1.74 [1.07-2.82],0.0255929785190119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,9317,19,1.66 [0.88-3.14],0.1209158193710988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,9527,22,0.93 [0.48-1.79],0.8246647397707776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,10831,27,1.67 [1.15-2.42],0.007047570820893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,10778,27,1.15 [0.60-2.24],0.6705518773665162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,9260,21,1.14 [0.51-2.56],0.746431738706482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,9580,22,0.42 [0.08-2.22],0.3068403043707831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,9543,22,1.55 [1.05-2.30],0.0277218922225154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,10741,27,0.93 [0.71-1.23],0.61783174986685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,9132,20,0.66 [0.24-1.79],0.4127334459071178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,9260,21,1.23 [0.53-2.82],0.6305711448457505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",10964,28,0.37 [0.13-1.00],0.0501601067824563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,11148,28,0.96 [0.44-2.11],0.925709946777822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,11024,27,0.76 [0.28-2.04],0.5847910873918551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,10778,27,1.11 [0.45-2.72],0.8265255413676265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,9564,22,1.33 [0.67-2.64],0.4120826024359002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,10723,27,1.02 [0.47-2.20],0.9535961343088803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,10741,27,1.25 [0.75-2.07],0.391447086344072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,10741,27,1.00 [0.76-1.31],0.9840103040424908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,11101,28,1.04 [0.30-3.58],0.9548029064109076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,10964,28,0.52 [0.10-2.66],0.4300645204333392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,10905,27,1.55 [0.46-5.18],0.4806991119500233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,9285,22,1.20 [0.67-2.16],0.5411985529411099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,10778,27,1.19 [0.79-1.80],0.4031765674928915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,9564,22,1.64 [0.96-2.82],0.0709608632306896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,9548,22,1.50 [0.75-3.02],0.2558511468764183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,10835,27,1.15 [0.42-3.10],0.7865752637905477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,10985,28,0.73 [0.36-1.48],0.3831412152396799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,10944,27,0.76 [0.17-3.42],0.7194776874331388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,11014,27,1.08 [0.91-1.29],0.3841132865027482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,10741,27,1.08 [0.90-1.30],0.398120569751326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,9354,21,0.30 [0.07-1.31],0.110649332773695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,10778,27,0.90 [0.44-1.81],0.7618716232436582
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,11024,27,1.16 [0.75-1.78],0.5017387152117407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,9549,22,0.72 [0.15-3.32],0.668432932366227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,9549,22,1.41 [0.87-2.28],0.1587936514852141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,9354,21,1.97 [0.83-4.69],0.1233348790146973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,9230,19,1.22 [0.53-2.77],0.641258038502675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,9298,19,1.33 [0.53-3.36],0.5411513052704622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,9543,22,1.56 [0.44-5.54],0.4900846249528423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,9537,22,1.44 [0.93-2.25],0.1043138537367465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,9288,20,1.08 [0.52-2.25],0.8362335387300555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,9288,20,1.52 [0.98-2.36],0.0638693619658549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,9230,19,0.45 [0.17-1.20],0.1103854682389396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,10571,26,0.40 [0.13-1.23],0.1093418773558975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,9337,21,0.51 [0.20-1.30],0.1556088889356551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,10944,27,0.95 [0.43-2.07],0.8970908399776638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,9288,20,1.32 [0.51-3.42],0.5619592405156476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,10812,26,1.22 [0.66-2.23],0.5273172693218247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,10977,28,0.86 [0.32-2.27],0.7586995594161585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,9253,22,1.37 [0.56-3.36],0.4961823683284573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,10949,27,0.82 [0.45-1.52],0.5354359647780538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",9354,21,1.53 [0.98-2.39],0.0594460331198131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,10778,27,0.78 [0.32-1.88],0.5786460113836962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,9529,22,1.15 [0.62-2.12],0.6540643336957626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,9338,21,1.43 [0.52-3.93],0.4881203094240701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,9564,22,1.88 [1.06-3.32],0.0303429329115288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,11159,28,0.68 [0.35-1.31],0.2474344864124771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,9354,21,1.83 [0.99-3.35],0.052259209157268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,9549,22,1.29 [0.88-1.89],0.1844393715819207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,10741,27,1.20 [0.73-1.98],0.4764184467697425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,9317,19,0.80 [0.29-2.18],0.6625898277133182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,11006,28,0.98 [0.52-1.82],0.9375506231958814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,9298,19,2.29 [1.21-4.30],0.0105401166710977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,9354,21,2.23 [0.78-6.38],0.1342070495401619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,9549,22,1.16 [0.69-1.94],0.5835891548402822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,11122,28,1.46 [0.34-6.21],0.605923205040855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,11019,27,1.06 [0.76-1.48],0.7346749841953026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,9537,22,1.89 [0.87-4.11],0.1081750441960914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",9577,22,0.85 [0.32-2.28],0.7535198543907282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,10973,28,0.57 [0.20-1.62],0.294987091204161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,9260,21,1.36 [0.74-2.49],0.3195212708758342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,10671,26,1.21 [0.84-1.74],0.3015471251285517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,9354,21,2.90 [0.79-10.60],0.1075489696062796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,10989,28,1.08 [0.74-1.57],0.7037112685680931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,10964,28,1.08 [0.84-1.39],0.5580474234191191
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,11112,28,0.76 [0.24-2.45],0.645702775175335
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,10944,27,0.56 [0.30-1.04],0.0686709802082605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,9529,22,1.13 [0.55-2.33],0.7474683433245657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,9537,22,0.56 [0.16-2.01],0.3730608084273101
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,9572,22,1.68 [0.79-3.56],0.1748198202230171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,9537,22,1.56 [0.81-3.02],0.1837324656833808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,10778,27,0.37 [0.08-1.68],0.197229309109944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,10727,27,0.46 [0.14-1.53],0.2068650341188433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,9253,22,1.04 [0.52-2.09],0.915028562629096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,9549,22,1.07 [0.37-3.08],0.9002121873196427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,9537,22,0.86 [0.46-1.62],0.635454895026018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,10812,26,0.93 [0.53-1.62],0.7899540564212706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,9529,22,0.42 [0.16-1.11],0.0796896724669074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,11024,27,1.06 [0.82-1.39],0.6444686150375114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,9564,22,1.30 [0.68-2.47],0.4274400963744466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",9549,22,0.94 [0.32-2.76],0.914732779658742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",9253,22,1.41 [0.88-2.25],0.1568881594389592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,10812,26,1.43 [0.86-2.36],0.168047551530272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,10950,28,1.05 [0.27-4.13],0.9404352732930245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,9298,19,1.25 [0.53-2.94],0.601833560049845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",10964,28,0.90 [0.51-1.57],0.7116180637623906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,9173,19,0.83 [0.47-1.46],0.5166899778666137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,10741,27,0.89 [0.55-1.44],0.6446249554692569
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,9530,22,0.51 [0.06-4.29],0.5390547787031719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",9525,22,3.41 [0.66-17.53],0.1426988891438492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,11007,27,0.77 [0.50-1.17],0.2193178958191106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,10741,27,0.59 [0.35-0.98],0.0435277046433951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,9260,21,1.07 [0.64-1.78],0.7959026494035577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,10707,27,0.68 [0.39-1.18],0.172963546628571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,9543,22,1.19 [0.99-1.43],0.0643187597838528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,9417,21,1.08 [0.63-1.88],0.7720676217943699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,9317,19,1.50 [0.89-2.52],0.1256861371010266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,10951,28,1.88 [0.69-5.11],0.2171508770004016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,9417,21,0.79 [0.41-1.53],0.4916302898121509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,9260,21,1.00 [0.33-2.98],0.997197947381879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,11051,28,0.99 [0.57-1.72],0.98054562156223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",10812,26,1.05 [0.73-1.53],0.7793506577514138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,11159,28,0.55 [0.20-1.56],0.2634840494581911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,11019,27,0.65 [0.36-1.15],0.1370530038890928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,10812,26,0.83 [0.50-1.37],0.4619028650394806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,9230,19,0.88 [0.32-2.43],0.8017337900897521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",9260,21,1.09 [0.61-1.94],0.762340062136301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",11086,28,0.73 [0.45-1.19],0.2082986543461122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,11112,28,0.84 [0.63-1.11],0.2188695425658854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",11006,28,1.11 [0.72-1.71],0.6474506808389109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,11097,28,0.98 [0.57-1.68],0.9294622828776076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,11006,28,0.88 [0.32-2.42],0.7968257086749503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,11086,28,0.96 [0.61-1.49],0.8423595739938757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,11112,28,1.11 [0.67-1.84],0.6909107419079028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,9564,22,1.22 [0.86-1.73],0.2743178319405208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,9260,21,0.76 [0.28-2.11],0.6013108322353014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,11159,28,0.92 [0.50-1.69],0.7947313942033256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,9288,20,1.16 [0.65-2.04],0.616893781173997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,9253,22,0.56 [0.22-1.40],0.2147846318803372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,9537,22,0.91 [0.36-2.29],0.839392791402004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,11098,28,0.82 [0.57-1.20],0.3104752926294494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,9543,22,1.62 [0.99-2.64],0.0548195098289816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,10812,26,0.73 [0.35-1.54],0.4149087536775643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,9354,21,1.17 [0.26-5.39],0.8367826744050266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,9543,22,0.93 [0.36-2.40],0.8848795383252214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,9564,22,1.53 [0.32-7.43],0.5959205396387044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,11019,27,0.90 [0.59-1.38],0.6295822276544192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,11159,28,0.68 [0.25-1.81],0.4389024936039133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,9487,22,1.01 [0.22-4.75],0.9853470884788352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,10741,27,1.20 [0.79-1.84],0.3944487826043332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,9543,22,1.25 [0.75-2.09],0.3889924243887532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,9288,20,0.68 [0.28-1.67],0.3974895933949876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,9260,21,1.45 [0.59-3.59],0.416221847443572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,9525,22,1.15 [0.54-2.44],0.7173897239762662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,9549,22,0.74 [0.26-2.06],0.5590265518274724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,10812,26,0.94 [0.26-3.43],0.9198358834434728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",9549,22,0.47 [0.14-1.60],0.2242524216902675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",10979,27,0.49 [0.18-1.32],0.1567433485415339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",11019,27,0.80 [0.22-2.85],0.7249487725264371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,11112,28,0.62 [0.28-1.39],0.2497665235078119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,9335,21,1.28 [0.60-2.70],0.5236329759767531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",9298,19,1.68 [0.93-3.04],0.0847500727542601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",9260,21,0.83 [0.30-2.31],0.7214109493156944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,9208,19,0.94 [0.37-2.38],0.8982468972141635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,10897,26,1.58 [0.81-3.08],0.184539746652166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,10778,27,0.79 [0.36-1.75],0.566634631813454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,9317,19,0.68 [0.29-1.63],0.3895793452009737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,10894,27,0.86 [0.42-1.77],0.6851885610748922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,10770,26,1.26 [0.83-1.93],0.2758904807459861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,9549,22,1.39 [0.73-2.67],0.3150106369996499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,11159,28,1.20 [0.76-1.91],0.4367508446837655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,10741,27,1.69 [0.72-3.96],0.2290007731786643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,9464,21,1.32 [0.84-2.06],0.227489156414664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,9404,21,1.10 [0.78-1.55],0.5709172865997107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,9298,19,2.06 [0.71-5.98],0.1856556022814053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,9537,22,3.00 [0.95-9.50],0.0621103857656285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,9298,19,1.87 [1.18-2.97],0.0082087532854869
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,10964,28,0.70 [0.28-1.70],0.4253437011961681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,11112,28,0.91 [0.33-2.51],0.8560704236959691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,9288,20,1.14 [0.36-3.59],0.8207727297892049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,9298,19,1.40 [0.90-2.18],0.1382183564639398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,11019,27,0.55 [0.24-1.27],0.1635003831076376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,9543,22,0.89 [0.46-1.72],0.7253516227209309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,9260,21,0.87 [0.35-2.20],0.7709387022345845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,9298,19,1.25 [0.52-3.05],0.6187379835069868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,10735,27,1.02 [0.62-1.68],0.9343312253504026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,11029,28,1.14 [0.73-1.80],0.5598123823404204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,9529,22,1.77 [0.95-3.32],0.0742535667752434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,10838,26,1.37 [0.79-2.35],0.2597565861124796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,11112,28,0.95 [0.41-2.22],0.9097606624769784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,10947,28,1.26 [0.35-4.61],0.7232007939871603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,9253,22,1.64 [1.24-2.18],0.0005953563584793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,9253,22,0.98 [0.37-2.59],0.9753671811994752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",11032,27,1.19 [0.70-2.05],0.519342662325478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,10963,28,1.61 [0.39-6.65],0.5123713843586254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,11148,28,2.28 [0.53-9.72],0.2660555982072115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,10831,27,1.14 [0.74-1.73],0.5570855044795797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,10972,28,0.45 [0.13-1.49],0.1895388031702324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,11148,28,1.03 [0.37-2.92],0.9500554765696396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,11148,28,0.39 [0.10-1.45],0.1586998682650391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,11019,27,0.93 [0.49-1.78],0.8336572230001363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,11024,27,1.12 [0.53-2.37],0.7638467931040682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,10964,28,0.14 [0.02-0.80],0.0271344599828294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,9417,21,1.10 [0.45-2.72],0.8329359477332926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,10778,27,0.68 [0.31-1.48],0.327942235619179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",9298,19,1.03 [0.52-2.06],0.9265920604136508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,11159,28,9.25 [1.56-54.76],0.0141654130895215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,11112,28,1.31 [0.63-2.70],0.4659122950914455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,9332,22,0.80 [0.26-2.40],0.6866916301514001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,9417,21,0.63 [0.25-1.57],0.3202113393330171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,9417,21,1.59 [0.61-4.11],0.3406775552532798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,9537,22,0.36 [0.13-1.01],0.051268107249898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,10831,27,0.97 [0.72-1.30],0.831442158391151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,11052,28,0.61 [0.11-3.26],0.5652713777493714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,10944,27,0.64 [0.32-1.31],0.2233789726341571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,10778,27,1.08 [0.49-2.39],0.8433475220737616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,9253,22,0.75 [0.32-1.75],0.5037601787645078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,11019,27,1.07 [0.42-2.69],0.8886414914212329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,9260,21,0.35 [0.07-1.86],0.2178066643233978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,9317,19,0.92 [0.34-2.49],0.869137129557272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,9549,22,1.39 [0.73-2.64],0.3107272905901099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,9253,22,1.00 [0.41-2.46],0.9974226592200408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,9577,22,1.06 [0.23-4.90],0.9394898291016572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,10964,28,0.48 [0.09-2.54],0.3870281444231348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,9260,21,1.15 [0.52-2.54],0.734902121304982
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,11006,28,1.58 [0.40-6.22],0.5147327617454076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,11131,28,1.00 [0.77-1.30],0.9859118765488828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,11129,28,1.07 [0.61-1.86],0.8230000668709648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,11063,28,2.43 [0.72-8.19],0.1521340860591841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,10875,28,1.02 [0.44-2.37],0.9548064704204132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,10980,28,0.72 [0.21-2.44],0.5938723723302015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,11148,28,0.95 [0.31-2.88],0.9269065550108522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,11024,27,1.15 [0.41-3.18],0.7894891589052776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,9288,20,0.79 [0.36-1.74],0.5571804844679749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,9260,21,1.20 [0.63-2.27],0.5755364542873932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,9568,22,0.33 [0.03-3.35],0.3501058968155274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,9230,19,0.94 [0.56-1.59],0.8303327338876082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,9298,19,1.77 [0.85-3.66],0.1242627185582898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,10964,28,0.66 [0.23-1.90],0.4420629644171343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,11024,27,0.53 [0.16-1.68],0.2783162860396426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,9564,22,0.73 [0.45-1.20],0.2197863186276974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,11019,27,0.95 [0.65-1.38],0.7755106233297159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,10741,27,1.06 [0.75-1.50],0.7572474489144758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,10831,27,1.07 [0.70-1.62],0.755184903131341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,10831,27,0.74 [0.34-1.64],0.4636618977058011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,11052,28,0.35 [0.10-1.20],0.0955726316949308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,10831,27,1.51 [1.03-2.21],0.0356669250651574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,10964,28,0.86 [0.54-1.37],0.5280033414000885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,11159,28,0.82 [0.44-1.52],0.5189989707514946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,10831,27,0.83 [0.33-2.08],0.6884441893229153
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,9288,20,0.97 [0.34-2.73],0.9513814735820167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,10831,27,0.75 [0.31-1.84],0.5366325462671406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,10855,27,0.59 [0.27-1.31],0.1951997099993959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,9253,22,1.68 [0.40-7.10],0.4785707850551031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,11019,27,1.62 [0.61-4.32],0.3376856010797208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,10831,27,0.85 [0.31-2.34],0.7554637498277736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,11159,28,0.62 [0.27-1.45],0.271029995377976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,10803,27,1.34 [0.70-2.56],0.3702490419850407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,10831,27,1.31 [0.86-2.00],0.2103077945291482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,10831,27,1.48 [0.67-3.26],0.3302690108152444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,10831,27,0.71 [0.39-1.30],0.2697215673905238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,11006,28,1.15 [0.54-2.46],0.7193730722488794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,10882,27,1.46 [0.77-2.75],0.2440382836778158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,10952,28,1.23 [0.60-2.51],0.5701227371781051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,11063,28,0.82 [0.26-2.60],0.7383813798517647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,11159,28,0.70 [0.25-1.95],0.4925122785366446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,10875,27,1.08 [0.89-1.31],0.4545689605327602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,10754,26,0.94 [0.57-1.54],0.8055125995571808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,10831,27,0.63 [0.29-1.35],0.2333509035807094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,10776,27,1.27 [0.78-2.09],0.3368556025937143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,10985,28,0.59 [0.13-2.62],0.4859438434585231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,10974,28,0.19 [0.04-0.92],0.0395248434612229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,11006,28,1.08 [0.52-2.27],0.8326138486034804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,11108,28,0.61 [0.32-1.17],0.1346254842256488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,10831,27,1.06 [0.43-2.64],0.9002106849394472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,10975,28,0.97 [0.52-1.82],0.9249520248047002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,10831,27,0.52 [0.18-1.52],0.2322916252396598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,10831,27,0.55 [0.22-1.37],0.1971553005885143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,10831,27,0.55 [0.20-1.50],0.2433852253813018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,9288,20,0.42 [0.15-1.20],0.1035667309646082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,9288,20,0.88 [0.34-2.28],0.7992019795217717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,9529,22,1.00 [0.54-1.82],0.988205360357493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,10831,27,0.49 [0.18-1.34],0.1636820225770822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,10831,27,1.55 [0.98-2.47],0.0607337091008179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,9195,19,1.02 [0.26-4.02],0.9817988927583038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,10952,27,1.15 [0.49-2.67],0.7499714169245422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,10831,27,0.57 [0.19-1.70],0.3122132235303775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,9529,22,0.69 [0.19-2.58],0.5834496933558138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,9230,19,0.64 [0.34-1.23],0.1788861494108174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,9288,20,1.41 [0.85-2.35],0.1876798694769653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,9259,20,0.62 [0.20-1.93],0.410386115250626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,11019,27,1.54 [0.75-3.16],0.2363596138347754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,10831,27,0.65 [0.27-1.53],0.3199698448980622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,10760,27,1.69 [0.61-4.69],0.3111209534150801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,9288,20,1.36 [0.82-2.25],0.2275299092705186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,9265,20,0.83 [0.40-1.74],0.6241212712311197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,10831,27,0.30 [0.10-0.91],0.0336585003574899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,10831,27,1.10 [0.72-1.70],0.6516374580380144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,11019,27,0.74 [0.28-1.94],0.5373189117324285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,10831,27,1.04 [0.82-1.31],0.7610612623739348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,11019,27,0.73 [0.39-1.38],0.335835158832159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,10964,28,1.15 [0.76-1.72],0.5050087183183148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,10954,28,0.86 [0.33-2.25],0.7560592494207122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,11024,27,2.37 [0.34-16.68],0.3865219085161429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,11019,27,1.23 [0.74-2.06],0.4276282858647529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,11006,28,0.83 [0.44-1.57],0.5722638070242371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,9417,21,1.36 [0.73-2.53],0.3320354189123466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,10758,27,0.80 [0.43-1.48],0.4716038106963595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,9529,22,1.61 [0.90-2.87],0.1073223433431769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,10944,27,1.13 [0.65-1.95],0.6704309999623442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,9543,22,1.12 [0.53-2.37],0.75959598022135
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,9253,22,0.53 [0.11-2.70],0.4470132361940184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,10760,27,1.01 [0.49-2.10],0.9790448169637144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,9354,21,1.30 [0.60-2.82],0.4996327578344361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,11006,28,0.78 [0.35-1.75],0.5520959183569591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,10964,28,0.96 [0.52-1.77],0.8922662470074814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",9298,19,1.52 [0.74-3.09],0.2521943891647332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",9549,22,1.09 [0.40-2.95],0.860926849762069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",10964,28,1.02 [0.73-1.44],0.8912743450906486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,9543,22,0.65 [0.42-1.01],0.0531161933830533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,9529,22,0.52 [0.17-1.59],0.2493292605932131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,9537,22,1.06 [0.71-1.58],0.776293592369824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,9288,20,0.91 [0.07-12.58],0.9465720963756268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,10924,27,1.09 [0.75-1.59],0.6595350104313058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,10964,28,1.08 [0.59-1.95],0.8088500989914671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",10812,26,1.02 [0.70-1.49],0.9177239917442892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,10831,27,1.05 [0.64-1.70],0.858469711291973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,11019,27,1.05 [0.75-1.46],0.7869834706541639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,10603,26,0.81 [0.32-2.01],0.6465411633728577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,11019,27,0.93 [0.39-2.19],0.8638045997904351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,9577,22,1.33 [0.69-2.57],0.3975918386777588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,9463,22,1.60 [1.03-2.47],0.0349453915508421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,11019,27,0.71 [0.25-2.00],0.5191522189888761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,9354,21,2.34 [0.71-7.73],0.1618383645615209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,11006,28,0.37 [0.09-1.52],0.1665038530618613
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,11019,27,0.81 [0.40-1.60],0.5384204122045375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,9288,20,0.64 [0.26-1.56],0.3245799042303758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,11006,28,1.17 [0.41-3.33],0.7676546929588581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,11112,28,1.20 [0.16-9.26],0.8577987062916932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,9417,21,1.42 [0.73-2.75],0.302835538862093
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,11010,28,0.70 [0.14-3.49],0.6592244985029139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,10741,27,1.13 [0.47-2.70],0.7828716333148489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,10812,26,1.13 [0.83-1.55],0.4361321087306454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,10955,28,1.06 [0.33-3.45],0.9214104197470322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,11032,27,1.31 [0.57-3.01],0.5303038782172853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,10831,27,0.89 [0.28-2.85],0.8496067491366686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,11112,28,0.85 [0.40-1.81],0.6811744715900739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,9577,22,0.52 [0.18-1.55],0.2428127005306849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,9580,22,3.02 [0.58-15.59],0.1872454873001802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,11063,28,1.69 [0.71-4.00],0.2348753766641838
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,9580,22,2.45 [0.70-8.62],0.1628336656014803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,9529,22,1.45 [0.66-3.16],0.3520103927168053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,11019,27,1.05 [0.60-1.82],0.8617287559773538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,9260,21,1.35 [0.76-2.43],0.3095933820916539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",9298,19,1.13 [0.62-2.07],0.688195943204555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",9253,22,1.23 [0.57-2.64],0.5978136869963326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",10778,27,1.66 [1.00-2.74],0.050280234202924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,9230,19,1.13 [0.49-2.64],0.7705174486776897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,11122,28,0.99 [0.26-3.87],0.9932254405319262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,9354,21,1.77 [0.85-3.70],0.128755518906465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,10831,27,0.68 [0.39-1.17],0.1599997499644617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,9230,19,0.47 [0.17-1.28],0.1390294241795662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,9537,22,1.42 [0.88-2.27],0.1485468407824841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,10831,27,0.54 [0.21-1.43],0.2165030739605911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,10964,28,1.13 [0.52-2.45],0.7491233917485072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,9537,22,1.50 [1.00-2.26],0.0506611545459128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,9253,22,1.46 [0.88-2.42],0.1464805183535968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,9317,19,1.23 [0.78-1.94],0.3719184270442023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,10778,27,1.40 [0.92-2.12],0.1148226531043371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,9346,20,0.94 [0.36-2.47],0.9033659355951996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,9288,20,0.94 [0.57-1.56],0.8051762311690329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,11032,27,1.59 [0.41-6.10],0.4990421960339736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,10778,27,0.66 [0.26-1.68],0.3801087227868427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,9230,19,0.63 [0.23-1.68],0.3548617430783437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,9298,19,1.26 [0.62-2.54],0.5197679101118626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,9543,22,0.88 [0.22-3.50],0.860804174963514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,9417,21,0.98 [0.53-1.82],0.9562331674426364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,9417,21,0.73 [0.15-3.54],0.700216277015329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,9529,22,0.68 [0.25-1.86],0.4543899582082163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,9260,21,1.02 [0.32-3.28],0.9754702183332958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,9253,22,0.94 [0.51-1.70],0.8267774747685691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,9260,21,1.29 [0.90-1.85],0.168252426830201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,10964,28,1.19 [0.79-1.80],0.3984024272685639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,9529,22,0.97 [0.60-1.56],0.9031869880988068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,10741,27,0.81 [0.51-1.28],0.365080992931223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,9537,22,0.92 [0.72-1.17],0.4897092084231809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,10741,27,0.72 [0.54-0.96],0.0263486010439941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,9230,19,0.74 [0.33-1.66],0.4620175262692462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,9253,22,0.55 [0.18-1.67],0.2936636509092178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,10778,27,1.03 [0.43-2.48],0.9439152372055646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,11052,28,0.41 [0.13-1.27],0.1210289473065732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,11024,27,1.24 [0.50-3.11],0.6404307354675092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,10778,27,0.92 [0.58-1.47],0.7337940816063131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,9253,22,0.86 [0.30-2.45],0.7810085368778706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,9549,22,0.90 [0.41-2.00],0.7968576431295196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,10904,27,1.08 [0.83-1.40],0.5624219888383986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,10996,26,0.80 [0.33-1.93],0.624261219551171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,10921,27,0.96 [0.30-3.06],0.9401752748522244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,10741,27,0.98 [0.76-1.26],0.8569682987085795
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,10747,28,1.22 [0.56-2.63],0.6179925983046559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,11112,28,1.43 [0.69-2.96],0.3418798456446972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,9512,22,1.24 [0.58-2.68],0.5817830940356249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,9577,22,0.79 [0.52-1.20],0.2673985159469241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,11112,28,1.48 [0.94-2.34],0.0891096680140544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,11008,27,1.13 [0.36-3.53],0.8273738512508814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,9136,18,0.48 [0.14-1.65],0.2442002681401923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,10626,26,1.23 [0.47-3.25],0.6764188029340517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,9403,21,2.22 [0.43-11.61],0.3439851971014515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,11159,28,0.70 [0.28-1.75],0.4452198501115578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,9253,22,1.25 [0.71-2.18],0.4392111131512416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,11159,28,1.27 [0.62-2.60],0.5165607667172167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,9288,20,0.41 [0.12-1.44],0.1630942327204585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,9543,22,0.91 [0.38-2.18],0.8275219671775957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",10452,26,1.30 [0.47-3.61],0.6162877270065481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",9260,21,0.59 [0.18-1.96],0.3853797382026308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",10964,28,0.83 [0.55-1.28],0.4051587273333722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",11006,27,0.79 [0.45-1.38],0.4080078244225378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",10778,27,0.61 [0.30-1.26],0.1801175931963657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",9260,21,1.03 [0.35-3.00],0.9563374969632584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",9253,22,0.54 [0.22-1.33],0.1811953540218766
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,11004,27,1.04 [0.57-1.90],0.8974121052721902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,11159,28,0.86 [0.41-1.82],0.6963852939426497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,11032,27,0.64 [0.21-1.96],0.4375058042490465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,9564,22,1.65 [1.07-2.55],0.0228820431836278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,9508,22,0.99 [0.40-2.46],0.977569443590592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,11024,27,1.23 [0.74-2.03],0.4197546178777911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,10964,28,1.05 [0.46-2.40],0.9112778212421514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,10994,28,1.06 [0.45-2.50],0.8906107173921878
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,10944,27,0.94 [0.68-1.29],0.6920485098629336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,9260,21,0.98 [0.44-2.16],0.952882404391127
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,11052,28,0.44 [0.16-1.26],0.126077413985778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,9298,19,2.05 [0.48-8.69],0.331378140487282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,9311,21,1.43 [0.44-4.61],0.5531352818369967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,10689,27,0.98 [0.18-5.26],0.978352144933515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,11138,28,0.50 [0.26-0.97],0.0417580401313063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,9529,22,1.15 [0.45-2.97],0.7678911075064249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,10831,27,1.31 [0.65-2.64],0.4534529804031136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,9529,22,1.41 [0.86-2.32],0.1777191368413677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,11159,28,1.17 [0.74-1.83],0.5032072925202244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,10964,28,1.00 [0.77-1.31],0.9705343056630548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,9288,20,1.60 [1.00-2.58],0.0522447652077703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,10926,27,1.22 [0.44-3.41],0.7004926410832704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,11063,28,1.38 [0.78-2.45],0.2653253703526905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,11122,28,0.88 [0.52-1.47],0.6129762660771598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,9572,22,2.66 [0.38-18.75],0.3250864100590238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,9549,22,1.22 [0.70-2.11],0.4826382378892933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,10700,27,0.78 [0.31-1.99],0.6071238452225158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,9577,22,1.61 [0.73-3.55],0.2328877445284098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,11035,27,0.83 [0.42-1.62],0.5850533952770252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,9549,22,1.33 [0.88-2.00],0.1705082690704423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,9564,22,0.63 [0.33-1.21],0.1631469902479996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,11101,28,0.69 [0.36-1.30],0.2521480307617044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,9009,20,1.43 [0.80-2.54],0.2237181492146512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,9253,22,0.83 [0.42-1.66],0.6043928474414972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,9549,22,0.51 [0.09-3.02],0.4603386564224925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEP,Leptin,11024,27,1.68 [1.02-2.76],0.0419265848589981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,11024,27,1.21 [0.41-3.52],0.7315310510309516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,9549,22,1.56 [0.83-2.93],0.1625414156665957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,11024,27,1.24 [0.47-3.24],0.6646407241270065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,11038,28,1.49 [0.49-4.54],0.4854299532955912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,9580,22,0.31 [0.06-1.49],0.1428484398124373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,10994,28,0.79 [0.42-1.50],0.4789964572118601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,10992,27,0.79 [0.33-1.84],0.5780604276137151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,11122,28,0.93 [0.54-1.61],0.8049343420550649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,11000,28,0.81 [0.26-2.55],0.721033994665832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,11052,28,0.63 [0.25-1.63],0.3434471945356194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,10741,27,0.70 [0.41-1.18],0.1770430633834594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,11013,28,1.24 [0.72-2.12],0.4327141489377449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,10778,27,0.68 [0.31-1.48],0.3321620683261254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,11019,27,0.43 [0.10-1.87],0.2619560566886852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,11006,28,0.85 [0.34-2.10],0.7183116175809149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,9577,22,1.94 [0.87-4.35],0.1059762792024696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,9260,21,0.83 [0.32-2.16],0.7045084943486508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,11014,27,1.33 [0.46-3.84],0.59655187043406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,9564,22,1.31 [0.75-2.30],0.3369381626262423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,11148,28,1.52 [0.45-5.11],0.502150102684194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,11089,28,2.14 [0.77-5.91],0.1433941282914221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,10831,27,0.74 [0.31-1.73],0.4794260259253163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,11148,28,1.11 [0.69-1.81],0.6637412895509944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,9298,19,1.44 [0.74-2.81],0.2859232866836196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,9517,22,0.71 [0.35-1.42],0.3329963298926963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,9543,22,0.84 [0.19-3.79],0.8260333434356155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,9549,22,1.56 [0.64-3.80],0.3281752191687765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,9253,22,1.01 [0.52-1.97],0.9726918105956588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",9298,19,1.80 [1.15-2.80],0.009669650268588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),9368,21,1.13 [0.90-1.44],0.2963923643649528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,10964,28,0.84 [0.33-2.18],0.7267752034716575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,11024,27,0.95 [0.48-1.90],0.8901505177275189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,10653,27,1.67 [1.00-2.81],0.0517200342921331
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,9260,21,1.81 [1.01-3.25],0.0451510822830959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,9260,21,1.34 [0.78-2.31],0.2825420913343605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,9317,19,0.63 [0.19-2.11],0.4500710325443136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,9580,22,0.76 [0.16-3.72],0.7393256767568352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,11086,28,1.39 [0.53-3.66],0.502748070540049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,9260,20,0.57 [0.10-3.39],0.537584800707583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,10964,28,1.13 [0.32-3.99],0.8525741885809823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,11024,27,0.93 [0.36-2.42],0.8791988073566058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,9317,19,1.79 [0.82-3.90],0.144568903887534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,9317,19,0.93 [0.50-1.74],0.8249858553389346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,11122,28,1.37 [0.84-2.23],0.2018062019129136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,10964,28,0.67 [0.27-1.68],0.3931430827527491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,9537,22,0.99 [0.38-2.55],0.9822611091619936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,9317,19,0.88 [0.32-2.39],0.7956218629468222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,9564,22,1.91 [0.98-3.73],0.0566247551484029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,9529,22,1.44 [0.69-3.03],0.3340269824719823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,10831,27,0.77 [0.33-1.81],0.5501361502541926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,9317,19,0.76 [0.24-2.42],0.6396803673604159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,9549,22,1.27 [0.26-6.19],0.7671131888532082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,10741,27,1.44 [0.92-2.26],0.1123495364362315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,9417,21,0.89 [0.49-1.62],0.6990141977216348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,11019,27,0.74 [0.30-1.78],0.4957101312958233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,11019,27,1.50 [0.67-3.37],0.3271834997572481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,11112,28,0.68 [0.36-1.29],0.2413710792495811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,9529,22,1.30 [0.50-3.42],0.5912492453561771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,11148,28,2.09 [0.80-5.47],0.1334166356457718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,10741,27,0.74 [0.36-1.51],0.4058023696765215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,10933,28,0.56 [0.16-2.00],0.3753043790031121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,10831,27,1.13 [0.51-2.51],0.7709473600180532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,9529,22,1.38 [0.63-3.06],0.4220887283499878
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LXN,Latexin,10892,27,1.00 [0.61-1.65],0.9910983731615702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,10939,28,0.86 [0.34-2.17],0.7440750076259821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,11019,27,1.26 [0.51-3.15],0.6147407662124478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,10904,28,0.79 [0.25-2.52],0.687529641995579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,10944,27,1.39 [0.61-3.17],0.4303145562278834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,10741,27,0.95 [0.49-1.84],0.8766264414566334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,10964,28,1.14 [0.77-1.69],0.5209451038119701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,10778,27,0.54 [0.22-1.33],0.1815870316121911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,10949,26,1.24 [0.44-3.55],0.6821467931225806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,10741,27,0.77 [0.38-1.57],0.4743050505899724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,9253,22,1.08 [0.76-1.52],0.6782710517761048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,9317,19,1.16 [0.80-1.67],0.4386922669138091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,9580,22,1.79 [0.22-14.58],0.5852753132335561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,9230,19,0.53 [0.13-2.09],0.3631928522511817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,9354,21,1.89 [1.11-3.23],0.0196818115451394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,9298,19,1.09 [0.35-3.39],0.876966249659563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,10912,27,0.82 [0.38-1.80],0.6253704634753714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,10741,27,1.17 [0.51-2.65],0.7152334719504594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,9317,19,0.51 [0.21-1.25],0.1401361848109781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,9417,21,1.22 [0.68-2.17],0.5061409561971784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,10741,27,2.04 [1.22-3.44],0.0070361730231951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,9564,22,1.80 [0.60-5.42],0.2969112394057392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,9529,22,0.74 [0.35-1.58],0.4427793248426324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",9298,19,3.25 [0.57-18.32],0.1824813286235488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,9564,22,0.75 [0.37-1.50],0.4113719432209035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",9230,19,0.90 [0.36-2.22],0.8119459417803598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,11052,28,1.09 [0.82-1.45],0.5459189622218823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,11032,27,0.73 [0.21-2.50],0.6115467854155985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,9260,21,0.94 [0.49-1.84],0.8656111468146083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,9253,22,1.25 [0.37-4.30],0.7188801867889829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,9260,21,0.82 [0.36-1.86],0.6309276959184166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,9543,22,1.74 [0.92-3.31],0.0883514201522966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,9537,22,1.61 [0.88-2.92],0.1201237365863888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,11019,27,0.97 [0.69-1.36],0.8529116605893581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,10741,27,1.09 [0.78-1.53],0.6086807315952989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,10926,27,1.10 [0.81-1.50],0.5493050139515274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,9230,19,0.77 [0.26-2.31],0.6403221732660765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,11019,27,0.90 [0.42-1.93],0.7768267431352724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,9417,21,1.39 [0.82-2.35],0.2245287929574023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,9230,19,0.82 [0.54-1.25],0.3564788292434737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,10778,27,1.01 [0.52-1.97],0.973803491352726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,11024,27,2.70 [0.68-10.71],0.1575103926243322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",9337,21,1.55 [0.96-2.49],0.0715852291656784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,10926,27,0.46 [0.11-1.96],0.2959075659768057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,11013,28,1.27 [0.41-3.93],0.680516150417317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,10924,27,1.70 [0.60-4.83],0.3193643097215616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,10741,27,1.10 [0.77-1.58],0.6031501226850281
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAX,Protein max,10778,27,1.17 [0.85-1.62],0.3353003780867875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,11148,28,0.90 [0.49-1.66],0.7318932815527016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,9453,21,0.98 [0.67-1.43],0.9246724097806936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,11063,28,2.45 [1.03-5.83],0.0419250814753179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",9549,22,0.86 [0.30-2.51],0.7863342786747297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,9288,20,1.17 [0.74-1.85],0.5050696569807139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,10964,27,1.24 [0.60-2.59],0.560767554634551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,9537,22,0.52 [0.08-3.20],0.4769943538942788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,10944,27,1.19 [0.72-1.95],0.5028346721186678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",9523,22,1.50 [0.57-3.98],0.4104587084639733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDK,Midkine,10993,27,1.10 [0.59-2.05],0.7695121917365015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,9317,19,2.13 [0.75-6.07],0.1583643410617669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",9298,19,1.77 [1.15-2.73],0.0093721265495416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,10741,27,1.27 [0.81-1.99],0.2970917366069491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,9260,21,0.38 [0.11-1.41],0.1487380759970654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,10994,28,1.04 [0.45-2.40],0.9308955130030198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,9260,21,1.04 [0.26-4.14],0.9611796158714846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,11108,28,1.02 [0.19-5.38],0.9790781913157776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,9564,22,1.41 [0.36-5.61],0.6239241045848973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,9354,21,5.40 [1.29-22.63],0.0211022912065419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,9537,22,0.82 [0.47-1.43],0.4870612269824749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,11024,27,1.33 [0.95-1.87],0.0912200869457942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,10994,28,0.84 [0.21-3.34],0.799843695478903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,11159,28,0.43 [0.11-1.69],0.2272918960825508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,11006,28,1.12 [0.85-1.46],0.4291010940337696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,11033,27,1.75 [0.29-10.40],0.5395884235679611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,10778,27,1.60 [0.61-4.17],0.3397273033596554
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",11019,27,1.10 [0.73-1.66],0.6417821927358962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,11101,28,0.83 [0.46-1.49],0.5307552754491808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,10812,26,0.91 [0.41-2.02],0.8237950350474333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,9317,19,0.21 [0.05-0.88],0.033458060312048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,9354,21,2.46 [0.70-8.62],0.1600650334030359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,11148,28,0.95 [0.41-2.20],0.8974198415349763
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,11006,28,0.57 [0.27-1.20],0.1406839649212576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,11038,28,1.03 [0.70-1.51],0.8813876974616729
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,11019,27,1.12 [0.84-1.51],0.4356121098623717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,11032,27,1.30 [0.53-3.19],0.5710499284365873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,9317,19,1.21 [0.69-2.11],0.5069929676469918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,11019,27,1.02 [0.81-1.30],0.8380625229525761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,10984,28,1.14 [0.69-1.90],0.6088000935031315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,10831,27,0.99 [0.51-1.93],0.9748418638086036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,9529,22,1.48 [1.00-2.19],0.0521178559439744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,9543,22,1.65 [1.03-2.64],0.0359127342047675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,10944,27,1.13 [0.79-1.62],0.4938536737236738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,9288,20,0.66 [0.17-2.55],0.5457583919099536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,9230,19,0.90 [0.43-1.89],0.7896534316930182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,11019,27,0.75 [0.52-1.08],0.1229138150093225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,10964,28,0.85 [0.55-1.33],0.480155616566122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,10663,28,1.20 [0.81-1.77],0.3601432427796301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,10982,28,1.36 [0.76-2.44],0.3024210968491815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,11038,28,0.78 [0.40-1.52],0.4633011069756109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,10778,27,1.10 [0.36-3.38],0.8712984645667774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,9564,22,1.02 [0.45-2.33],0.9634005156895608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,11006,28,0.76 [0.37-1.53],0.4374619548633465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,10799,26,1.35 [0.65-2.83],0.4183745301085899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,11103,27,0.86 [0.53-1.39],0.5454881279834062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,10994,28,1.10 [0.63-1.92],0.7282784105625231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",9260,21,0.92 [0.40-2.13],0.854260313601288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,9317,19,1.03 [0.48-2.22],0.9314091271778956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,9417,21,0.74 [0.26-2.11],0.5757975134468314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,11007,27,0.90 [0.62-1.30],0.5704669180005375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,9354,21,1.49 [0.83-2.67],0.1799802641393669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,11112,28,1.12 [0.40-3.10],0.8283212627122442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,9543,22,0.83 [0.18-3.89],0.8141754574738344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,9417,21,1.01 [0.38-2.69],0.9794169349312234
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,9230,19,1.07 [0.35-3.30],0.9106975133125528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,9230,19,1.22 [0.79-1.88],0.3641668909455758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,10812,26,1.19 [0.77-1.84],0.4286968753465026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,10964,28,1.08 [0.74-1.58],0.681747734386556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,11038,28,0.99 [0.64-1.53],0.9600983056015258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,11006,28,0.78 [0.36-1.66],0.513760976020401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,9516,22,0.97 [0.39-2.43],0.9506398254526828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,9572,22,1.43 [0.35-5.87],0.6230252754432193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,9317,19,0.98 [0.51-1.90],0.9598393050304246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",9260,21,0.38 [0.10-1.53],0.1752518343407093
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",9549,22,0.38 [0.06-2.38],0.3010259066123304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",10778,27,1.21 [0.37-3.92],0.7536464354267624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",9208,19,1.24 [0.22-6.94],0.8031510217558027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",9549,22,1.65 [1.17-2.34],0.0044186685147785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",9288,20,0.81 [0.16-4.03],0.7954848429018662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,10947,28,0.43 [0.21-0.88],0.0203361207262453
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,9317,19,1.34 [0.42-4.32],0.623975525527015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,10989,27,0.45 [0.28-0.72],0.0009232461872472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,11122,28,1.09 [0.51-2.30],0.8292353065129806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,11032,27,1.22 [0.77-1.93],0.4072585513511042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,9446,22,1.38 [0.59-3.23],0.4573278074897198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,10812,26,0.97 [0.51-1.85],0.9187146966432532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,9288,20,1.82 [1.17-2.83],0.0080560085566469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",9543,22,1.07 [0.22-5.30],0.9308890197777594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,9417,21,1.31 [0.91-1.88],0.1408369842578017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",9537,22,1.64 [1.05-2.55],0.0295010888184228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,10812,26,0.98 [0.32-2.94],0.9688718158155644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,9260,21,0.59 [0.24-1.45],0.2464137119883177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,9537,22,1.22 [0.85-1.74],0.2780319697651763
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,9529,22,1.68 [1.12-2.52],0.0121023379508772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,9417,21,1.14 [0.54-2.40],0.737197996679753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,10778,27,1.12 [0.59-2.14],0.7264062745447524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,10964,28,1.01 [0.85-1.21],0.884541933450482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,9577,22,1.14 [0.74-1.76],0.5542918475091477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,9230,19,0.85 [0.26-2.82],0.7890352023381986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,10831,27,0.80 [0.51-1.24],0.315732326634816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,9354,21,4.29 [1.14-16.08],0.0308717043568444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",9564,22,1.21 [0.75-1.96],0.4316188008827537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",9298,19,1.20 [0.78-1.85],0.3998353597968578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,9549,22,1.41 [0.82-2.42],0.2133910279353568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,9564,22,1.45 [0.98-2.14],0.064117065311054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,9260,21,1.23 [0.55-2.76],0.6079752300082255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,9230,19,0.60 [0.17-2.12],0.4315621614508527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,9577,22,1.41 [0.98-2.01],0.0616297830316632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",9260,21,1.38 [0.66-2.90],0.3900411819989967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,9298,19,1.68 [1.03-2.74],0.03877531521241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,9298,19,1.21 [0.56-2.61],0.6336745369568837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,9317,19,0.85 [0.49-1.48],0.5712070417575339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",9317,19,1.10 [0.52-2.36],0.7983961936412595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,9549,22,1.25 [0.57-2.74],0.5852625003891643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,10831,27,0.95 [0.56-1.59],0.8364293294478713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,11006,28,0.99 [0.46-2.10],0.96965765266301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,9253,22,1.73 [1.15-2.59],0.0083018150448775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,9260,21,0.99 [0.48-2.07],0.9880090032199992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,9354,21,1.40 [0.93-2.11],0.1064345694045514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,11027,28,1.07 [0.55-2.10],0.8328619951147705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,10741,27,0.84 [0.42-1.69],0.6329273198617746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,9260,21,1.21 [0.52-2.79],0.66039298157713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,9317,19,1.38 [0.97-1.97],0.076360814973186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,10896,27,1.25 [0.73-2.15],0.411414947549375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,9529,22,1.32 [0.71-2.48],0.3813558353911214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,11024,27,0.82 [0.42-1.59],0.556960591304887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,9274,20,1.13 [0.60-2.10],0.7085127448771213
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,9283,18,1.87 [0.93-3.77],0.0784317475342391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,9354,21,2.19 [0.29-16.30],0.4452454560266453
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,10741,27,0.93 [0.46-1.87],0.8360614813369572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,9515,22,2.49 [0.84-7.37],0.0994007892906596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,9543,22,0.80 [0.22-2.86],0.734018457009263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",9549,22,1.99 [0.80-4.95],0.1374844427456568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,11032,27,1.17 [0.33-4.24],0.8065626362327168
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,10831,27,0.73 [0.33-1.62],0.4366164040674516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,11063,28,0.82 [0.29-2.30],0.7107000271236782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,11006,28,0.31 [0.09-1.08],0.0664848902599251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,11122,28,1.61 [0.65-3.99],0.299815386886198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,10994,27,0.84 [0.54-1.31],0.4500476575809771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,11052,28,1.12 [0.82-1.53],0.4785677872019916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,10831,27,0.56 [0.20-1.55],0.2648255192410111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,11006,27,0.65 [0.25-1.67],0.3682041485879751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,9537,22,1.19 [0.37-3.83],0.7713622014923022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,11112,28,1.76 [0.53-5.88],0.3577308053679749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,10778,27,0.95 [0.56-1.63],0.8615737334628144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,9529,22,1.22 [0.68-2.19],0.5118171086899606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,9266,20,2.56 [1.08-6.04],0.0324032620993425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,9537,22,1.50 [0.97-2.33],0.0705188065228816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",10741,27,1.13 [0.77-1.67],0.5319981340374951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,9260,21,0.95 [0.31-2.92],0.9228670616114008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,9260,21,1.11 [0.59-2.08],0.7411480462650266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,9288,20,0.60 [0.14-2.59],0.4945442921815102
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,11014,27,1.10 [0.34-3.55],0.8726565665975506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,11032,27,1.34 [0.47-3.81],0.5871642069622186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,9288,20,2.23 [0.83-6.05],0.1135320612210095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,9288,20,0.65 [0.15-2.72],0.5530136424081349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,10745,27,1.40 [0.71-2.74],0.3325183723128726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,9417,21,1.33 [0.87-2.03],0.1866977421801811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,11032,27,1.70 [0.76-3.78],0.1970976533032186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,11052,28,0.77 [0.24-2.52],0.6708788355402238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,9529,22,0.92 [0.61-1.37],0.6687165752787867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,9549,22,0.48 [0.07-3.25],0.4506961457948659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,9572,22,1.75 [1.11-2.74],0.0153971250732467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,11159,28,1.55 [0.50-4.75],0.4473435502453057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,9288,20,1.19 [0.74-1.92],0.4648383901301196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",11019,27,0.86 [0.61-1.22],0.3893904585816213
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",10831,27,0.56 [0.29-1.08],0.0841576889150544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,9298,19,1.60 [0.91-2.80],0.1018147552134386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,9549,22,0.83 [0.27-2.55],0.7452912306560401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,9260,21,1.41 [0.82-2.43],0.2187871196811875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,9417,21,1.20 [0.70-2.05],0.5127792391226083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,10741,27,1.57 [0.86-2.86],0.1394687170598226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",9537,22,1.53 [1.04-2.25],0.0309193085628382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,9260,21,1.25 [0.69-2.29],0.4645400290559797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,9260,21,0.76 [0.21-2.70],0.6665315220359764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,10944,27,3.05 [0.58-15.99],0.1876732627757942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,9564,22,1.51 [0.60-3.80],0.3767739763415376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,9543,22,1.80 [0.44-7.39],0.4158960660774154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,9159,19,0.75 [0.18-3.02],0.6820397877986144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,11031,28,0.85 [0.34-2.14],0.7332525080656485
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,11006,28,0.71 [0.44-1.13],0.1433441189680275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,10741,27,0.90 [0.44-1.80],0.7561313362368065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,9298,19,2.88 [0.89-9.38],0.0784550414827104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,9522,22,1.45 [0.84-2.51],0.1800432299617611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,9317,19,1.10 [0.61-1.98],0.7465438886514963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,9253,22,0.96 [0.39-2.39],0.9296204081577016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,9288,20,3.88 [1.13-13.33],0.0315842604257129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,11013,28,0.55 [0.12-2.57],0.4495642604147184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,9484,22,1.61 [1.05-2.48],0.0287518860800224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,10944,27,0.84 [0.50-1.41],0.4990425828673546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,9230,19,0.92 [0.27-3.13],0.8998347609072053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,9549,22,1.23 [0.76-1.99],0.4079914195625034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,11006,28,0.63 [0.15-2.58],0.5203543194924749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,9260,21,1.15 [0.85-1.55],0.3795740245008976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",10778,27,0.85 [0.46-1.57],0.6039642709997255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",9260,21,1.20 [0.45-3.23],0.7177970240888789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",10778,27,0.80 [0.38-1.71],0.572093240519987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,11148,28,0.22 [0.03-1.94],0.1728874600798742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,9577,22,1.35 [0.22-8.27],0.7436965074152391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,11148,28,1.47 [0.55-3.88],0.4415502331500973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,9413,21,1.27 [0.34-4.69],0.7246941471564179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,11024,27,1.01 [0.33-3.08],0.9869295189296542
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,9288,20,1.02 [0.29-3.62],0.9799609844122754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,9288,20,0.91 [0.57-1.44],0.6797062366618917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,9564,22,0.98 [0.39-2.46],0.9683017649023312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,10812,26,1.25 [0.94-1.65],0.1204680671365652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,11019,27,0.63 [0.31-1.29],0.2070207689133766
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,9260,21,0.53 [0.14-1.94],0.3343999491539783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,10741,27,1.01 [0.65-1.57],0.9551718714531648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,11006,28,0.98 [0.44-2.20],0.957530321628514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,9577,22,1.19 [0.37-3.90],0.7698878363164936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,11024,27,0.72 [0.25-2.06],0.5398953001440479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,11112,28,0.87 [0.52-1.46],0.5992563560429032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,11024,27,1.07 [0.31-3.64],0.915424259104882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,9572,22,1.33 [0.86-2.05],0.2032568687754867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,9549,22,0.79 [0.22-2.90],0.7276143714766057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,11087,28,2.95 [0.95-9.15],0.0604787700899124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,11006,28,0.97 [0.29-3.23],0.9640265079459888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,10831,27,1.03 [0.53-1.99],0.9397788451330872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,9317,19,0.66 [0.15-3.03],0.5968803681170447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,11122,28,1.02 [0.61-1.72],0.9366487241933272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",9564,22,1.60 [0.94-2.72],0.0805016244769016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,9543,22,2.09 [0.99-4.42],0.0537426625604199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,10995,27,1.14 [0.76-1.72],0.5183721985524621
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,11032,27,1.02 [0.55-1.88],0.9614623639167192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,11019,27,0.51 [0.19-1.41],0.1958271434891889
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,10741,27,0.51 [0.15-1.75],0.2831625998060719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,11024,27,1.11 [0.28-4.45],0.8792826846784019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,11122,28,6.13 [1.28-29.29],0.0229516709408575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,11024,27,1.26 [0.94-1.70],0.1234039323355451
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,11019,27,0.97 [0.64-1.45],0.8755334032374205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,9529,22,0.65 [0.41-1.03],0.0682778326760262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,11102,28,0.97 [0.40-2.35],0.947312253123999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,11159,28,1.07 [0.63-1.80],0.8068426598762163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,9298,19,1.37 [0.40-4.73],0.6168245119989988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,9260,21,0.99 [0.41-2.41],0.9774188669978668
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,9524,22,1.43 [0.93-2.21],0.1053716902831365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],10964,28,0.90 [0.49-1.64],0.7243692065175709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,11006,28,1.10 [0.57-2.13],0.7853223349018422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,9288,20,1.69 [0.99-2.89],0.0529832702564925
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,9260,21,0.67 [0.14-3.19],0.6177576322369802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,9260,21,0.80 [0.18-3.45],0.7612572238744446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,10778,27,0.95 [0.39-2.33],0.908536339642842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,9288,20,2.03 [0.53-7.77],0.3001000639253406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,10907,27,0.67 [0.38-1.18],0.1660040277180897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,9549,22,1.13 [0.45-2.85],0.7975437589382733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,10760,27,1.40 [0.88-2.21],0.1557117679015167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,9417,21,1.13 [0.65-1.97],0.6665800656104732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,9537,22,1.55 [0.89-2.70],0.1181968186236515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,10964,28,0.64 [0.22-1.87],0.4138701201173345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,11006,28,1.31 [0.59-2.90],0.512779156610319
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,9417,21,0.68 [0.30-1.57],0.3680039219121496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,9016,20,1.15 [0.80-1.65],0.4476273338790318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,10920,27,1.08 [0.63-1.86],0.7858416589924818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,11052,28,0.95 [0.42-2.15],0.905962938851494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,10964,28,0.85 [0.53-1.38],0.5101395474079402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,9253,22,0.55 [0.18-1.64],0.2814844809286564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,9543,22,1.44 [0.99-2.10],0.0545799102668801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,9298,19,1.20 [0.65-2.21],0.562913404956189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,10964,28,0.44 [0.19-1.05],0.0652028217011478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,9546,22,1.38 [0.19-10.27],0.7502672223167394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,9543,22,0.80 [0.22-2.89],0.7327761927725399
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,11013,28,0.65 [0.25-1.70],0.3782928138501902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,10961,27,1.04 [0.63-1.69],0.8890792946871067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,11087,28,2.04 [0.38-10.83],0.4030199985065914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,9317,19,1.19 [0.42-3.34],0.7468565085945916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,9253,22,1.32 [0.72-2.41],0.3748279725474287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,9537,22,1.60 [0.82-3.13],0.1659134538578192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,9549,22,1.63 [0.89-3.00],0.112924805907679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",9298,19,2.11 [1.22-3.67],0.0079023703498364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,11122,28,0.93 [0.74-1.17],0.5421961199783953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,10946,26,1.01 [0.42-2.43],0.982904874480368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,9260,21,1.48 [0.79-2.77],0.2198561423916846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,10831,27,0.68 [0.31-1.48],0.3312875523794776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,10760,27,0.80 [0.47-1.37],0.4152681250873485
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,10944,27,1.07 [0.77-1.48],0.6884115729733064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,9549,22,0.97 [0.68-1.38],0.8504395594576326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",9417,21,1.53 [0.78-3.02],0.2197283816099955
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,10812,26,0.69 [0.35-1.36],0.284856994326304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,9298,19,1.97 [1.15-3.37],0.0135857696711117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,9210,19,0.59 [0.23-1.52],0.2746226806450447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,10778,27,0.94 [0.54-1.64],0.8167286224537439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,9288,20,0.57 [0.14-2.36],0.4364857455884761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,9479,22,2.69 [1.12-6.47],0.027427996785432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,9543,22,0.84 [0.28-2.47],0.7461211250684333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,9260,21,0.86 [0.45-1.65],0.6587749720640594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,11098,28,1.24 [0.36-4.21],0.7353788772612735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,11006,28,1.25 [0.35-4.43],0.7268239054775316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,10831,27,0.93 [0.45-1.92],0.8497632290202369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,9417,21,1.33 [0.86-2.04],0.1984428460611814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,11006,28,1.15 [0.60-2.20],0.6758619379832291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,11019,27,0.66 [0.31-1.44],0.2992100937246508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,9354,21,1.67 [0.74-3.74],0.2162343515951698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,9230,19,0.54 [0.14-2.17],0.3895462311058926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,10778,27,0.60 [0.30-1.23],0.1654781632957354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,9537,22,1.77 [0.62-5.07],0.286077146252463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,9253,22,1.16 [0.80-1.69],0.4224520314587514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,9333,21,0.78 [0.31-1.97],0.5961004899069574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,9549,22,1.83 [1.06-3.18],0.0309948625936471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,11118,28,0.27 [0.04-1.70],0.1631019149212046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,9549,22,0.98 [0.20-4.84],0.9831060263506088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,11024,27,1.01 [0.40-2.56],0.981486223856904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,9537,22,0.77 [0.22-2.65],0.6807752135435206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,9537,22,1.55 [0.45-5.26],0.485096848967627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,9529,22,1.25 [0.46-3.37],0.6661017654984588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,9230,19,0.54 [0.18-1.59],0.2643850390852938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,9529,22,0.77 [0.29-2.07],0.6028136009251374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,11148,28,0.72 [0.31-1.68],0.4514652000590535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,9537,22,1.63 [0.95-2.79],0.0774847711434303
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,9564,22,1.43 [0.94-2.16],0.0919544093217354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,11094,28,0.96 [0.40-2.35],0.93581728422275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,10964,28,0.68 [0.23-2.00],0.4856590644363687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,11122,28,1.14 [0.65-2.01],0.64699120388011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,11024,27,1.15 [0.67-1.98],0.60752392815073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,9230,19,0.25 [0.07-0.87],0.0300028427175042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",9230,19,0.88 [0.34-2.25],0.7844734610692188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",9260,21,1.10 [0.61-1.99],0.7601156982238476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",9354,21,1.61 [1.03-2.52],0.0380015047224376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,11148,28,0.88 [0.56-1.39],0.5979352317936352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,11052,28,0.90 [0.61-1.31],0.5806824420264995
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,10741,27,1.57 [0.51-4.80],0.4277008629918779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,11024,27,1.25 [0.37-4.22],0.7232957591579833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,11148,28,0.71 [0.28-1.80],0.4708900825520682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,9230,19,0.50 [0.13-1.96],0.3213931691703006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,9354,21,1.06 [0.19-5.85],0.950174370584105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,9577,22,1.75 [0.98-3.13],0.0578076536114918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,9230,19,1.21 [0.65-2.27],0.5475327583034055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,9549,22,1.54 [1.04-2.26],0.0293902619218666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,11052,28,1.06 [0.82-1.38],0.6450166490319824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",10741,27,0.93 [0.45-1.90],0.833929642091735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,9317,19,0.60 [0.20-1.76],0.3521987190676111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,9230,19,0.79 [0.25-2.51],0.6877636462875227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,9260,21,1.62 [0.94-2.78],0.0833846149425021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,9288,20,0.35 [0.10-1.19],0.0928504240577936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,11148,28,0.63 [0.15-2.71],0.537566408621625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,11006,28,0.90 [0.50-1.63],0.7353621402738606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,11006,28,0.47 [0.15-1.49],0.2018428704531646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,9298,19,2.57 [1.15-5.70],0.0207356531172204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,9354,21,1.79 [0.67-4.79],0.2491527228597067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,9572,22,4.03 [0.95-17.05],0.0584309596121854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,9288,20,0.87 [0.60-1.26],0.4640073781276365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,9507,22,0.97 [0.64-1.47],0.8801282725624163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,10778,27,0.69 [0.37-1.31],0.2614523847780964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,9230,19,0.91 [0.39-2.14],0.836666687909005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,9317,19,0.72 [0.30-1.78],0.4820495067191409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",10949,28,0.88 [0.57-1.37],0.5719968357555794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,9572,22,1.55 [0.88-2.76],0.1306302166271113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",9564,22,1.61 [0.79-3.28],0.1938777696196461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,11159,28,1.42 [0.38-5.38],0.6030569808316809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,11089,28,0.70 [0.30-1.65],0.420132420840779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,9462,22,0.39 [0.10-1.46],0.1632543929679104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,9260,21,1.13 [0.63-2.04],0.6845961567385953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,9317,19,1.51 [0.97-2.35],0.0666909811406253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,9288,20,0.91 [0.57-1.47],0.707944396052327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,9549,22,1.44 [1.00-2.06],0.047921917932611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,9537,22,1.67 [0.84-3.33],0.1436462272138173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,9230,19,1.51 [1.13-2.02],0.0049759074729411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,10944,27,1.44 [0.46-4.49],0.5338681236809603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,9354,21,2.06 [0.76-5.56],0.152979514410933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,9572,22,0.24 [0.04-1.35],0.1050849527438917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PI3,Elafin,10858,28,1.16 [0.66-2.05],0.5990120966390096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",9549,22,1.73 [1.08-2.76],0.0218910103678089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,10873,28,0.65 [0.26-1.66],0.370852038072196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,11019,27,0.88 [0.50-1.54],0.6493081799658571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,11006,28,0.55 [0.14-2.16],0.3943943639575885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,9288,20,1.45 [0.86-2.44],0.1670526779361828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,11006,28,1.36 [0.60-3.11],0.4635621936651828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,11024,27,1.34 [0.71-2.54],0.370828941384009
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,9354,21,1.30 [0.69-2.43],0.416968388417171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,9210,19,0.80 [0.38-1.67],0.5499935097726578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,9564,22,2.29 [0.49-10.65],0.2896633858756247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,9260,21,1.11 [0.56-2.18],0.7709600300883968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,11015,28,0.97 [0.58-1.63],0.9000774114482524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,9417,21,0.91 [0.51-1.63],0.7556407064842241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,10944,27,0.73 [0.43-1.24],0.2449878339250587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,11032,27,0.67 [0.21-2.18],0.5099440118766083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,11131,28,1.26 [0.58-2.71],0.5585343569372657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",10993,28,0.91 [0.46-1.80],0.7808916447039473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,11052,28,1.13 [0.77-1.64],0.5363840521763936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,11006,28,0.51 [0.19-1.40],0.1914744171087149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,11108,28,0.61 [0.32-1.15],0.1241380506971933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,11006,28,0.87 [0.26-2.93],0.8283212312954653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,10920,28,0.60 [0.18-2.05],0.4142673683128369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",9543,22,0.71 [0.37-1.37],0.311313496470447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",9288,20,0.79 [0.25-2.50],0.693138872319115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",9543,22,1.41 [0.92-2.14],0.1108415390318002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,9543,22,1.59 [0.92-2.73],0.0942386425444466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,9345,21,0.43 [0.07-2.77],0.373125511342862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,10778,27,1.64 [0.76-3.53],0.2028925150913942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,11024,27,1.31 [0.62-2.76],0.4803732416979405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,11024,27,0.97 [0.58-1.62],0.9036916218498215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,9525,22,1.90 [0.98-3.67],0.0574223197807977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,11111,28,1.68 [0.67-4.25],0.2696098295444837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,10741,27,0.61 [0.18-2.09],0.436305402703427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,9543,22,0.30 [0.06-1.45],0.1352684801338195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,11019,27,0.97 [0.63-1.48],0.8713084613697889
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,11095,28,1.30 [0.33-5.11],0.7104379522472255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,10986,27,0.91 [0.44-1.85],0.7893347637223037
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,10987,27,1.13 [0.93-1.38],0.2224927919493754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,9260,21,0.92 [0.51-1.66],0.7864436085324755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,9260,21,1.76 [0.91-3.39],0.0920586159936825
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,9317,19,0.97 [0.41-2.28],0.9484387600863984
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,10761,27,1.30 [0.89-1.90],0.1745753325495045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,9572,22,1.43 [0.84-2.43],0.1905728380005502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,9543,22,1.31 [0.81-2.11],0.2740696422608685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,10994,28,1.03 [0.92-1.16],0.5993863564294002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,9298,19,1.72 [1.06-2.77],0.0271346806836713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,9253,22,0.85 [0.30-2.40],0.7600596537974209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",10831,27,1.09 [0.84-1.41],0.5275292981083021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,10964,28,0.47 [0.05-4.12],0.4917179546694388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,11032,27,0.75 [0.22-2.53],0.6412200984914678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,9288,20,1.06 [0.41-2.73],0.9039812613915296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,9288,20,0.95 [0.22-4.10],0.9402034551555508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",10964,28,0.47 [0.13-1.67],0.245947328166463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,9298,19,1.63 [0.95-2.79],0.0735127291074164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,9572,22,0.87 [0.18-4.13],0.8595586529269262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,10812,26,0.73 [0.27-1.99],0.5441100015512216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,11052,28,1.26 [0.37-4.28],0.7073812153720169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,9577,22,1.69 [0.56-5.09],0.3516275465630947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,9505,22,0.98 [0.61-1.57],0.9310057617830416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,11122,28,1.36 [0.68-2.71],0.3847241177087008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,11010,28,1.09 [0.77-1.55],0.6072466998901516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,9417,21,1.07 [0.58-1.96],0.8368828282735066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",9577,22,1.42 [0.87-2.30],0.1572394489605673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,9288,20,0.62 [0.15-2.53],0.5006380290454251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,10741,27,1.35 [0.57-3.17],0.4938178267561725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,9288,20,1.16 [0.66-2.04],0.6175251475079928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,9564,22,1.64 [0.79-3.39],0.1818481154406513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,10964,28,0.81 [0.46-1.43],0.4668902970787846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,9529,22,1.69 [1.10-2.60],0.016061774626114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,11032,27,1.14 [0.81-1.62],0.4533524671966736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,9417,21,0.99 [0.53-1.84],0.9747897532823218
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,9549,22,1.40 [0.88-2.23],0.1550284454296068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,9549,22,2.43 [1.28-4.63],0.0067616117127391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,11024,27,1.14 [0.76-1.72],0.5331002862845632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,11159,28,1.05 [0.74-1.48],0.7898460076171916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,9537,22,1.39 [1.01-1.90],0.0416416330543308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,10944,27,1.73 [0.78-3.81],0.1764384795830345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,9317,19,1.51 [1.07-2.13],0.0204992139614645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,10961,27,1.27 [0.92-1.75],0.152165181527054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,10741,27,0.61 [0.28-1.36],0.2292211296189059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,9230,19,1.00 [0.16-6.16],0.9961351061616875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,9577,22,0.48 [0.19-1.23],0.1244791574087156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,9529,22,0.47 [0.10-2.23],0.3439246546014051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,11074,28,1.09 [0.37-3.20],0.8745973401551025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,10722,27,1.14 [0.80-1.64],0.4700699778005235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,9428,21,0.81 [0.41-1.62],0.5543873445479898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",10831,27,1.13 [0.71-1.80],0.6180947303766036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",11159,28,1.23 [0.73-2.09],0.4357221283840303
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,11112,28,0.96 [0.55-1.68],0.8902843745014835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,10831,27,1.01 [0.30-3.38],0.993561008607061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,10994,28,0.83 [0.21-3.29],0.7881876355882423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,9577,22,1.10 [0.49-2.44],0.8166293889922523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,9577,22,1.13 [0.51-2.51],0.7579912726057012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,10831,27,0.78 [0.40-1.52],0.4668396155519487
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,9317,19,1.24 [0.31-4.87],0.7621697967131844
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,11024,27,1.07 [0.71-1.61],0.7439465536753374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,9522,21,1.51 [0.90-2.55],0.1220877761303355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,10831,27,1.42 [0.78-2.58],0.2512353210330776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,9260,21,1.09 [0.43-2.80],0.8551373619358938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,9354,21,1.65 [1.18-2.31],0.0035152905749303
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,10741,27,1.15 [0.70-1.89],0.5727622782714957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,11122,28,1.08 [0.69-1.69],0.7413567702033536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,9543,22,0.95 [0.41-2.24],0.9139364733880616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,11052,28,0.87 [0.24-3.16],0.82854813960515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,9260,21,0.53 [0.11-2.45],0.4123134686887519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,11019,27,0.53 [0.26-1.11],0.0932968641150437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,9580,22,3.05 [0.80-11.60],0.1012612615133789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,9286,21,1.34 [0.77-2.32],0.2966672706527461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,9288,20,1.24 [0.56-2.79],0.5948096895711057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,9298,19,2.07 [0.80-5.35],0.1331003096954034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,11063,28,1.46 [0.85-2.51],0.1758404186001396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,9288,20,0.65 [0.17-2.52],0.53854156890739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,10984,27,0.88 [0.38-2.08],0.7789915526714521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,9543,22,0.54 [0.19-1.51],0.2376526295534632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,10962,28,0.47 [0.20-1.11],0.0853741938568222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,10778,27,1.16 [0.84-1.60],0.3587177898197863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,11112,28,0.80 [0.20-3.18],0.7535444652346501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,10745,28,0.91 [0.44-1.90],0.7986210141536852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,9417,21,1.28 [0.33-4.91],0.7183585426624695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,9492,21,2.06 [0.53-7.94],0.2945514735852523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,9537,22,0.91 [0.41-2.04],0.8258248369905381
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,9537,22,1.20 [0.98-1.47],0.0857618659251931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,10944,27,1.35 [0.93-1.97],0.1181593164591152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,11019,27,0.65 [0.34-1.23],0.1837307479257881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,10741,27,1.02 [0.49-2.11],0.9667798704224624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,9230,19,0.42 [0.09-1.88],0.2546575968834579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,9549,22,1.15 [0.54-2.46],0.7191039501264176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,9317,19,0.78 [0.28-2.21],0.644655713498512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,10964,28,0.72 [0.37-1.38],0.3242543658193704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,10935,27,1.19 [0.47-3.03],0.7123145465014225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,10897,27,1.17 [0.45-3.07],0.7423308801005015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,11019,27,0.77 [0.38-1.55],0.4584539423366702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,9288,20,1.02 [0.48-2.15],0.9612707453496748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,11019,27,0.82 [0.56-1.20],0.3011994213252181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,10741,27,0.88 [0.48-1.60],0.675310830997589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,9016,19,1.87 [1.14-3.04],0.0123870463498148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",10778,27,0.94 [0.30-2.91],0.9090905692176274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,10944,28,1.02 [0.32-3.21],0.9731030601543792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,9220,20,1.89 [0.92-3.90],0.0851561838202704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,9564,22,0.97 [0.59-1.58],0.8953988867845493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,9317,19,1.24 [0.76-2.03],0.3836583415426404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,11019,27,1.22 [0.61-2.44],0.5798909058035497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,10778,27,0.48 [0.22-1.04],0.0613925445411219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,10812,26,0.95 [0.47-1.92],0.8932760426297793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,9288,20,0.71 [0.27-1.87],0.4865261071782466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,10944,27,1.02 [0.66-1.57],0.9257903089976312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,11038,28,1.18 [0.80-1.75],0.4089355317175021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,9271,20,1.88 [1.03-3.41],0.038750233952958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,9564,22,0.34 [0.09-1.31],0.1170527233829446
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,9577,22,1.00 [0.15-6.53],0.9978107940596096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,11148,28,2.27 [0.69-7.45],0.1750753509995527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,9537,22,0.73 [0.31-1.72],0.476328150168416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,9537,22,0.90 [0.13-6.43],0.919528524259202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,10999,27,0.41 [0.10-1.67],0.2141147381997206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,10906,27,1.58 [0.57-4.36],0.3792578517327052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,9543,22,1.59 [0.61-4.15],0.3414122011050837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,11148,28,0.46 [0.12-1.79],0.2611063200839979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,9564,22,2.20 [0.57-8.41],0.2511158087645998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,9354,21,1.71 [0.85-3.45],0.1352400899460765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,10725,27,0.91 [0.48-1.71],0.7698493126641842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,9417,21,1.35 [0.61-2.98],0.4628885010694491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,11019,27,1.42 [0.66-3.05],0.3665177465201984
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,11074,28,1.23 [0.90-1.68],0.1959815247147944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,11122,28,0.73 [0.29-1.84],0.5050849523025678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,9529,22,0.68 [0.26-1.77],0.4337465860523283
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,10778,27,0.79 [0.39-1.58],0.5034308895442183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,9298,19,1.47 [0.59-3.69],0.4117389181080632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,9260,21,0.78 [0.49-1.25],0.3096210430869479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,9580,22,0.42 [0.10-1.70],0.2234773339407647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,10963,27,0.96 [0.43-2.15],0.9115285028450304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,11008,28,0.65 [0.19-2.23],0.4975263029094257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,9387,21,1.07 [0.37-3.12],0.8949774120243612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,9564,22,1.68 [0.85-3.32],0.1383887457400722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,9564,22,1.45 [0.99-2.14],0.0592658719309787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,9564,22,1.80 [1.00-3.26],0.0510785437166826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,9529,22,1.52 [0.88-2.64],0.134963672102987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,9260,21,1.45 [0.85-2.48],0.168592863888913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,10831,27,0.93 [0.60-1.43],0.7272828347879989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,9260,21,1.09 [0.72-1.65],0.689461420892624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,9253,22,1.26 [0.76-2.08],0.3693652015316556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,9529,22,1.06 [0.48-2.35],0.8790641925254556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,11019,27,0.96 [0.45-2.07],0.9186686365600626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,10778,27,1.28 [0.69-2.37],0.428352497873929
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,9354,21,1.59 [0.94-2.68],0.0864178426196072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,10741,27,0.91 [0.50-1.66],0.7543785304027839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,10831,27,0.86 [0.47-1.57],0.6203498548771513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,9317,19,0.72 [0.29-1.79],0.4846132866483654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,10741,27,1.24 [0.60-2.57],0.5531862435908167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,9417,21,0.92 [0.37-2.24],0.8484956201406683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,9288,20,1.99 [0.65-6.13],0.2313406632130256
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,9529,22,0.89 [0.37-2.16],0.7998509021335116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,9298,19,2.46 [1.18-5.14],0.0165340497720269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,9253,22,1.37 [0.43-4.41],0.59298490566709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,10741,27,0.68 [0.29-1.55],0.3558512505829759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,9288,20,0.89 [0.43-1.81],0.7404436490874553
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,9417,21,1.48 [0.73-3.02],0.2791752742797756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,10741,27,0.64 [0.19-2.18],0.479140197999865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,11087,28,1.14 [0.58-2.21],0.7073000649463381
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,10778,27,1.40 [0.61-3.19],0.4292705866344061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,9230,19,0.88 [0.31-2.50],0.8160601258040289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,10741,27,0.90 [0.47-1.71],0.7498262470385109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,9549,22,1.49 [0.66-3.37],0.3393700407270922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,10784,27,0.73 [0.37-1.47],0.383476855061131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,9549,22,1.44 [0.90-2.31],0.1297306834619382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,9260,21,0.43 [0.12-1.54],0.1971077453237212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,9230,19,0.71 [0.25-2.02],0.5213085344966459
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,9317,19,1.03 [0.57-1.88],0.9144739886231348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,10964,28,1.14 [0.74-1.76],0.5533955559321189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,10964,28,0.88 [0.48-1.63],0.6905828614273498
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,9537,22,1.28 [0.75-2.19],0.362872573730381
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,9288,20,0.76 [0.34-1.72],0.5140845558275081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,9298,19,1.65 [1.11-2.46],0.0143354461870908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,9529,22,0.82 [0.32-2.10],0.6843996160017862
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,10812,26,0.92 [0.39-2.14],0.8404674641363358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,9298,19,5.59 [0.73-42.53],0.0967603168811515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,9549,22,1.25 [0.69-2.25],0.4676837293123794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,10961,28,1.43 [0.79-2.59],0.2377412762902799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,11148,28,1.44 [0.88-2.35],0.1456900987196669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,11148,28,1.06 [0.62-1.82],0.822583214383733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,9529,22,1.06 [0.36-3.14],0.9140780001308704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,11013,28,1.29 [0.67-2.49],0.450692769598547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,9288,20,1.51 [0.74-3.09],0.2537099544812539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,11006,28,1.08 [0.32-3.68],0.8999721802633871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REN,Renin,11024,27,0.82 [0.50-1.34],0.4277331540990309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,9288,20,1.35 [0.48-3.85],0.570886591431865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,9230,19,0.81 [0.20-3.28],0.7623425992480427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,10964,28,0.58 [0.23-1.45],0.2447138031934582
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RETN,Resistin,10994,28,0.45 [0.21-0.98],0.0434308804557287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",9260,21,0.21 [0.05-0.92],0.0387614473340328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,9529,22,0.63 [0.09-4.67],0.6528796368757286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,9549,22,1.72 [0.99-2.99],0.0528538847438576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,9417,21,0.67 [0.28-1.63],0.3759842721262068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,11122,28,0.79 [0.28-2.27],0.6680754947558831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,11122,28,0.80 [0.23-2.85],0.7339650478354964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,9549,22,1.61 [0.89-2.91],0.1123609465897821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,10831,27,0.99 [0.57-1.70],0.9576542543406938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,10890,27,1.19 [0.88-1.61],0.253163258435305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,9288,20,0.74 [0.24-2.32],0.6061314654796713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,9354,21,0.44 [0.17-1.13],0.0877797183967442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,11086,28,0.87 [0.49-1.54],0.6373975831898844
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,9564,22,1.58 [1.02-2.45],0.0397875193879444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,9260,21,0.88 [0.42-1.82],0.7231758522960252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,9549,22,0.29 [0.04-2.24],0.2345702704792851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,9338,21,0.24 [0.10-0.55],0.0007972596179357
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,9572,22,1.70 [0.46-6.30],0.4258396994367898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,9298,19,1.14 [0.47-2.79],0.7690102487966191
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,10967,27,0.85 [0.61-1.19],0.3368460516360835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,9280,21,1.15 [0.24-5.46],0.8575078202499099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,9510,22,0.88 [0.20-3.81],0.8638376322336141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,9549,22,1.21 [0.58-2.52],0.6187892869239271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,11096,28,0.62 [0.16-2.35],0.4817253746976906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,9298,19,1.37 [0.35-5.36],0.6475363461411578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,9288,20,0.96 [0.34-2.73],0.93741117669212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,9288,20,1.22 [0.40-3.73],0.7285472489817603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,9417,21,0.84 [0.41-1.71],0.6232337173280293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,10741,27,1.06 [0.64-1.75],0.8340285759334264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,9417,21,1.32 [0.71-2.43],0.3780787277811149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,9298,19,2.07 [1.02-4.21],0.0435260982410727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,11013,28,0.86 [0.20-3.75],0.845785391546244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,11122,28,1.14 [0.25-5.17],0.8633636548288139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,9298,19,3.93 [0.35-43.88],0.2666275551360249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,11024,27,0.90 [0.30-2.68],0.8466470268902295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,10964,28,1.17 [0.55-2.50],0.6826509755768304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,9288,20,1.73 [0.53-5.57],0.361184428314665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,9417,21,1.20 [0.71-2.04],0.4981592521423831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,9317,19,1.51 [0.62-3.69],0.3644680191212204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,9298,19,0.84 [0.25-2.79],0.7712697107700566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,9260,21,1.45 [0.65-3.20],0.3641212494864307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,9317,19,1.44 [1.06-1.95],0.0196098056964977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,10741,27,0.72 [0.31-1.69],0.4502007326327084
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,10741,27,1.05 [0.64-1.72],0.8618995372996177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,9253,22,1.26 [0.83-1.91],0.2703850874511571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,10944,27,0.71 [0.26-1.94],0.5012534428083069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,11112,28,0.61 [0.16-2.26],0.4600455818339216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,10964,28,0.98 [0.31-3.12],0.9747401225945772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,9260,21,0.70 [0.25-1.93],0.4865463624130134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",9549,22,1.62 [1.07-2.45],0.0227749074240979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,11112,28,0.45 [0.16-1.24],0.1229528858952762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,10741,27,1.21 [0.91-1.63],0.1957493738626884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,11122,28,1.08 [0.63-1.84],0.7795502538892403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,9260,21,1.26 [0.41-3.93],0.6887066731828897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,10937,27,1.11 [0.58-2.14],0.7544411720647614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,10848,28,1.11 [0.70-1.75],0.6605760301356549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,9288,20,1.55 [0.56-4.34],0.399971941282449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,9549,22,1.25 [0.61-2.58],0.5387444854481933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,10760,27,0.90 [0.50-1.62],0.7191742211159659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,9529,22,1.26 [0.64-2.48],0.5013030401099577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,11032,27,0.82 [0.45-1.51],0.5236914768857504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,9549,22,0.92 [0.38-2.22],0.8586323782795766
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,10812,26,0.64 [0.30-1.37],0.2494902581144076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,9580,22,0.28 [0.01-5.08],0.3860280631665644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,9549,22,1.33 [0.34-5.24],0.6871645022265215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,9253,22,2.05 [1.34-3.12],0.000881121009078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,11019,27,1.02 [0.65-1.61],0.9311716137914914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,9417,21,0.76 [0.38-1.53],0.4369054331185644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,9537,22,1.30 [0.89-1.90],0.177499954806475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,9260,21,1.23 [0.53-2.84],0.6250402740629375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,9260,21,0.98 [0.41-2.33],0.9576688573438248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,9417,21,0.67 [0.32-1.40],0.2881220891785033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,9549,22,0.89 [0.19-4.11],0.883230558123976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,9562,21,1.08 [0.33-3.51],0.8977864965130828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,10964,28,1.00 [0.67-1.49],0.9990665453596757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,11122,28,0.90 [0.28-2.87],0.8610067731672477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,10778,27,1.27 [0.79-2.04],0.3166010380848827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,10730,27,1.49 [0.50-4.49],0.4752120071700573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,11148,28,0.72 [0.32-1.63],0.4328869879131193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,11122,28,0.94 [0.27-3.27],0.9200121700556024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,11076,28,0.64 [0.22-1.87],0.4174064229641414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,11013,28,0.59 [0.21-1.62],0.3041197609888932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,11021,28,1.08 [0.57-2.05],0.8205998706782079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,9260,21,1.85 [0.69-4.99],0.2214420985701551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,9354,21,1.36 [0.26-7.08],0.7152164704653667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,11038,28,1.12 [0.74-1.70],0.5820266013718631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,10831,27,1.31 [0.60-2.85],0.4945627138362752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,9253,22,0.70 [0.37-1.33],0.27499100461974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,11086,28,0.88 [0.44-1.80],0.7350403848500777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,9253,22,1.66 [0.97-2.82],0.0630126950067392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,9317,19,0.28 [0.05-1.61],0.1525530906508263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,9317,19,0.76 [0.20-2.93],0.6891039387397591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,9253,22,0.43 [0.13-1.44],0.170176029754583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,9298,19,1.72 [0.71-4.15],0.2272614905312359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,10741,27,1.13 [0.76-1.68],0.5532540479788226
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,9268,18,1.75 [0.79-3.90],0.1708548719144033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,9564,22,1.37 [0.47-3.96],0.5611082015088301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,9298,19,0.89 [0.51-1.56],0.6802761033952476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,11019,27,1.06 [0.58-1.94],0.8471967108363243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCT,Secretin,9317,19,0.73 [0.27-1.98],0.5320589750887834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,11024,27,1.29 [0.56-2.99],0.5450802822302407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,11024,27,0.67 [0.33-1.37],0.2740282936740424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,9529,22,1.28 [0.89-1.82],0.1825582287114385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,9537,22,1.45 [0.90-2.34],0.1287993770160117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,9354,21,1.45 [0.48-4.39],0.5104482756472183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,9298,19,2.12 [1.12-4.02],0.0213468314235348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,9298,19,1.41 [0.68-2.95],0.3590022452823981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,11148,28,0.78 [0.40-1.51],0.4593930133302745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,9580,22,6.05 [2.54-14.42],4.940644621903215e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,9580,22,1.25 [0.21-7.44],0.8039310663407815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,11063,28,0.86 [0.47-1.56],0.61539021344999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,11019,27,0.33 [0.14-0.81],0.0149044546830317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,11024,27,0.61 [0.16-2.31],0.464655207509176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,9354,21,1.91 [0.94-3.91],0.0746901064091105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,10964,28,0.55 [0.14-2.12],0.3891343677866481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,11122,28,0.85 [0.29-2.53],0.7735719129876508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,9288,20,2.53 [1.00-6.42],0.0509628635487966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,11108,28,1.61 [0.51-5.13],0.4190039966949062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,9549,22,0.80 [0.45-1.41],0.4355379790759055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,9417,21,1.43 [0.78-2.60],0.2455023014665317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,9523,22,1.59 [0.54-4.68],0.398374545898147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,10964,28,0.84 [0.26-2.77],0.7794754043678485
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,9422,22,0.41 [0.00-69.99],0.7320197073085203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,11148,28,1.35 [0.59-3.06],0.4737733747637648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,10713,26,0.99 [0.73-1.35],0.9462662706978132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,9555,22,3.21 [0.41-24.85],0.2640679759475423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,9421,21,1.67 [0.27-10.39],0.5844846687252638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,9452,21,0.57 [0.12-2.72],0.484721423051716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,9580,22,0.60 [0.04-8.69],0.7109372786894581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,9580,22,0.29 [0.03-2.67],0.2765746371976356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,10922,28,1.07 [0.66-1.73],0.7953159643755747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,10972,28,1.00 [0.69-1.45],0.984104560484496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,10812,26,0.87 [0.43-1.78],0.7001001336985742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,11087,28,1.00 [0.58-1.75],0.9871841664649088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,11159,28,0.92 [0.50-1.68],0.79100404964772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,10944,27,1.60 [0.56-4.59],0.3822408368642263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,9565,22,2.46 [0.14-43.44],0.539102336017942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,9565,22,1.39 [0.33-5.78],0.6513823930388496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,11148,28,0.72 [0.45-1.16],0.1785717165082346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,9564,22,0.92 [0.50-1.70],0.788057577134947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,9446,21,1.09 [0.23-5.25],0.917226020318946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,9412,21,8.53 [0.58-125.40],0.1181087021243042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,9565,22,,
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,9417,21,1.56 [1.13-2.15],0.0072705001539151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,9337,21,0.74 [0.16-3.39],0.7005358779284432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,9537,22,1.17 [0.60-2.26],0.6458592083592269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,10778,27,1.11 [0.66-1.87],0.6868594650561967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,10903,27,0.83 [0.25-2.73],0.7629158977308623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,9317,19,1.71 [0.53-5.58],0.3725036089582725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,11032,27,0.83 [0.24-2.88],0.7750244802050379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,10964,28,0.48 [0.11-2.04],0.3212675544320073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,10964,28,1.25 [0.82-1.91],0.3040556627457564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,10904,27,1.35 [0.67-2.70],0.3998260667911331
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,9354,21,0.83 [0.29-2.37],0.7214945937624879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,10741,27,1.13 [0.66-1.94],0.6582361623192066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,10741,27,0.64 [0.31-1.32],0.2268810392095674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,11024,27,1.03 [0.62-1.70],0.913704156859649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,9419,22,1.19 [0.62-2.31],0.5971796899211554
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,10741,27,1.17 [0.82-1.67],0.3824348550451915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,11019,27,0.44 [0.20-0.94],0.0342873148154209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,9253,22,1.17 [0.67-2.06],0.5781813595926284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,9537,22,0.96 [0.42-2.18],0.9154767347293294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,9350,21,0.82 [0.51-1.32],0.4184508571269677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,9543,22,1.34 [0.73-2.47],0.3437168211660628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,9572,22,0.63 [0.27-1.49],0.2947797652649676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,9230,19,0.85 [0.55-1.31],0.4603316640416064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,9245,21,0.65 [0.29-1.45],0.2899105664845715
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,9288,20,0.77 [0.27-2.26],0.6405491412199618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,9577,22,1.41 [0.38-5.20],0.6039049790620847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",11038,28,1.02 [0.69-1.51],0.9136204570908892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,9417,21,0.77 [0.23-2.51],0.6592009977763827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,11012,27,1.01 [0.49-2.07],0.9825398647634596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,11052,28,1.26 [0.56-2.80],0.578898516974832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,11019,27,0.76 [0.26-2.21],0.6086228683149911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,10778,27,0.62 [0.32-1.22],0.1655230913012935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,11006,28,1.04 [0.77-1.40],0.8070020970604406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,11112,28,0.64 [0.24-1.71],0.3687048625200835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,11024,27,0.68 [0.20-2.35],0.5452619626797839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,9298,19,0.78 [0.29-2.07],0.6154685151802202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,11097,28,3.55 [1.20-10.56],0.0225238511089181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,9298,19,0.94 [0.26-3.44],0.9243176808942332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,11036,28,0.73 [0.43-1.24],0.2419266741029663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,10971,28,1.29 [0.62-2.68],0.4907702712287062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,9288,20,1.10 [0.73-1.67],0.6444635515478936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,10964,28,1.18 [0.80-1.73],0.404033746575185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",10778,27,0.49 [0.21-1.11],0.0866721789191358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,10831,27,0.47 [0.24-0.92],0.0269761769688701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,10926,27,0.69 [0.42-1.14],0.1440970783314681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,11052,28,1.05 [0.76-1.44],0.7702548709527092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,9260,21,0.93 [0.32-2.74],0.8972037889342591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,9549,22,1.49 [1.01-2.20],0.0463555069949994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,10831,27,1.06 [0.59-1.92],0.8463187532874722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,10741,27,0.74 [0.30-1.86],0.5221778608937734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,11019,27,1.15 [0.64-2.05],0.6462179951839194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,10741,27,0.92 [0.48-1.76],0.7915301335852851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,9260,21,1.37 [0.38-5.01],0.6294979357415689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,9529,22,0.95 [0.45-2.01],0.8936153475673878
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,10778,27,0.68 [0.33-1.41],0.2993187687933284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,9317,19,1.22 [0.62-2.40],0.5695952299880176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,10778,27,0.89 [0.52-1.51],0.6565597480322374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,9230,19,0.63 [0.24-1.68],0.3568510984449708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,9230,19,0.86 [0.30-2.49],0.7855268627893702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,10778,27,0.86 [0.29-2.57],0.7937471473664943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,11019,27,0.86 [0.44-1.67],0.6492070720238987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,9317,19,1.35 [0.89-2.05],0.1524443553590233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,9577,22,1.30 [0.58-2.91],0.5273421447567219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,9260,21,1.07 [0.61-1.88],0.8124370707945368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,9354,21,1.56 [0.98-2.50],0.0634006418254698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,9537,22,0.77 [0.30-1.96],0.5850509746873571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",9230,19,0.83 [0.35-1.97],0.6708311619511154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,10778,27,0.81 [0.40-1.64],0.557061611902091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,9288,20,1.67 [0.51-5.52],0.3976230619264935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,11112,28,0.72 [0.32-1.66],0.4453757126711349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,10812,26,2.19 [0.90-5.30],0.0823951550208658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,9417,21,1.24 [0.82-1.87],0.3036712971020857
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,9537,22,1.62 [1.05-2.50],0.0290299284035968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,9514,21,1.49 [0.62-3.58],0.3670646694414051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,10741,27,1.12 [0.75-1.66],0.5893239599797588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,9529,22,1.48 [0.86-2.56],0.153971709103885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,9529,22,1.97 [0.99-3.92],0.0525622096237471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,10964,28,0.32 [0.08-1.21],0.092924029016996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,10778,27,0.93 [0.57-1.53],0.7897862733345491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,9230,19,0.96 [0.41-2.25],0.923873979944546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,9537,22,0.94 [0.47-1.85],0.8480634001671561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,11112,28,0.63 [0.22-1.80],0.390357300858094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,11052,28,0.83 [0.34-2.04],0.6880287913003336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,11069,28,1.16 [0.60-2.23],0.658017908708007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,9288,20,0.99 [0.48-2.04],0.9733999342173216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,11029,28,0.69 [0.42-1.13],0.1372080105864928
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,9529,22,0.96 [0.53-1.72],0.879810571274383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,9253,22,0.98 [0.51-1.88],0.9548527466837644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,9522,22,1.32 [0.91-1.94],0.1475934247106636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,11024,27,1.04 [0.70-1.54],0.8603232433640655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,9253,22,2.09 [0.95-4.61],0.0661005077308594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,11032,27,1.05 [0.73-1.52],0.7900334621131008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,9549,22,1.22 [0.63-2.37],0.5538764111868443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,9354,21,1.23 [0.85-1.77],0.2779716900481397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,10944,27,0.84 [0.50-1.42],0.5144095971552796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",9298,19,1.14 [0.28-4.63],0.8512758074042024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',9543,22,0.80 [0.26-2.43],0.688296367070541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,9260,21,1.41 [0.89-2.24],0.1394743714257419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,9354,21,1.12 [0.52-2.43],0.7687299467397108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,9537,22,1.12 [0.48-2.58],0.7951150993637196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,9529,22,1.23 [0.82-1.85],0.3193902517698428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,9298,19,2.79 [0.92-8.43],0.0696374167747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,11024,27,1.16 [0.71-1.89],0.5479836670990768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],10801,26,0.93 [0.45-1.93],0.8394902276994698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",11006,28,1.43 [0.63-3.22],0.3917895039582719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,9572,22,1.46 [0.99-2.16],0.0560429937507164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,9549,22,1.39 [0.69-2.83],0.3584114752251363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,10741,27,0.83 [0.30-2.29],0.7251396187416528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,11066,28,0.72 [0.48-1.07],0.0996232770797705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,11014,27,0.98 [0.40-2.40],0.9626281805305472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,11014,27,0.44 [0.19-1.06],0.0689314653234559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,9317,19,0.85 [0.30-2.43],0.7637561070156227
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,9527,22,0.99 [0.17-5.67],0.9878667414335662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,9317,19,1.37 [0.28-6.74],0.701672664435103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,9549,22,0.84 [0.19-3.68],0.8220384153000349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,9549,22,1.29 [0.79-2.11],0.3072848727820044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,11032,27,0.83 [0.53-1.30],0.4224878026158599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,11024,28,1.15 [0.36-3.59],0.8162008858526049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPART,Spartin,9354,21,1.46 [0.87-2.45],0.1566387599924337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,9564,22,1.26 [0.39-4.14],0.6987131175922585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,11006,28,1.41 [0.62-3.21],0.409738237295236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,9354,21,1.40 [0.49-3.94],0.5286631368898065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,11019,27,1.20 [0.72-2.01],0.4791077724361184
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,11006,28,1.07 [0.41-2.81],0.8843286168563431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,11112,28,1.21 [0.64-2.28],0.5612698993609166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,9260,21,0.71 [0.19-2.74],0.6227680037306389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,10963,28,0.86 [0.23-3.22],0.8180038890229591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,11052,28,0.83 [0.37-1.91],0.6688822227927769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,9537,22,0.78 [0.62-0.97],0.0235923759315185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,10944,27,1.12 [0.30-4.23],0.8633907907825615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,11013,28,1.44 [0.57-3.65],0.4368260394823445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,10972,27,1.03 [0.36-2.91],0.9580395565126856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,11129,28,1.41 [0.64-3.07],0.3918460137817598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",9288,20,1.28 [0.53-3.07],0.5844075933286257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,9230,19,0.88 [0.40-1.95],0.7511422468920026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,9417,21,0.65 [0.32-1.30],0.2219783054096642
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,9543,22,1.27 [0.68-2.38],0.4596993512313461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,10831,27,1.23 [0.86-1.75],0.2490632680298223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",9253,22,1.02 [0.29-3.53],0.9770472168466922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,9543,22,1.21 [0.44-3.37],0.7120421058139901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,11015,27,1.15 [0.86-1.54],0.3406718149674257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,10964,28,0.80 [0.46-1.40],0.4335161559205305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,11019,27,1.01 [0.67-1.50],0.9710198923087096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,9564,22,0.62 [0.22-1.75],0.3674975904985813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,10778,27,1.33 [0.84-2.10],0.2174857816677998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",9288,20,1.48 [0.65-3.39],0.3504253580163926
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,11014,27,0.85 [0.64-1.13],0.2534579987728816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,11063,28,0.90 [0.41-1.96],0.7846691711245174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,9230,19,0.73 [0.14-3.72],0.7057090651498594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,9537,22,1.31 [0.61-2.77],0.4883801976212425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,9354,21,1.62 [0.74-3.52],0.2270977267278675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",10964,28,1.03 [0.48-2.20],0.9441341578849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",11148,28,1.19 [0.38-3.74],0.7706405189586173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",9288,20,1.00 [0.41-2.46],0.9994189088049176
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,9577,22,1.05 [0.25-4.49],0.9430319394208412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,9529,22,0.94 [0.30-2.98],0.9128678784097908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,10926,27,1.15 [0.67-1.97],0.6142416594903095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,9288,20,1.51 [0.91-2.50],0.1108722606248151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,10964,28,1.07 [0.84-1.37],0.5821519160477119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,9230,19,1.09 [0.58-2.06],0.7887719063972468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,11122,28,0.95 [0.45-2.01],0.8934992200765433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,10991,28,0.50 [0.13-1.89],0.3048547430723494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,9253,22,1.25 [0.87-1.81],0.227821718675678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,10984,28,1.16 [0.70-1.94],0.5597364698526293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,10812,26,1.27 [0.79-2.04],0.3287075665359519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,10778,27,1.15 [0.67-1.98],0.6056545177595094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,11024,27,1.07 [0.73-1.57],0.7270864595647921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",9230,19,0.72 [0.41-1.27],0.2607413870306221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,10741,27,1.42 [0.93-2.18],0.108544669975773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,9317,19,1.26 [0.56-2.82],0.5724859983433832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,9543,22,0.66 [0.17-2.58],0.5490113139429511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,10964,28,0.63 [0.31-1.27],0.1984142423527558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,9288,20,1.06 [0.41-2.75],0.9059722858543352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,10741,27,1.00 [0.61-1.66],0.9909484146262024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,9288,20,1.22 [0.50-2.94],0.6631750397552392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,11019,27,0.97 [0.48-1.96],0.9358994369490704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,9549,22,2.81 [1.56-5.06],0.0005532576572879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,10741,27,0.95 [0.45-2.00],0.8841707768256974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,9537,22,1.16 [0.45-2.98],0.7603549105895717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,10741,27,1.27 [0.82-1.97],0.2894843348624575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,11122,28,1.07 [0.82-1.39],0.6200480386965503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,11019,27,0.92 [0.50-1.69],0.7896914514789514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,9288,20,1.00 [0.53-1.87],0.9929497095605964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,11122,28,0.95 [0.52-1.76],0.874352307042355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",9549,22,0.70 [0.34-1.47],0.3489833867151528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,10812,26,0.97 [0.47-2.00],0.9311565904092404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,11006,28,1.04 [0.32-3.41],0.9422182167463092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,9529,22,1.57 [0.65-3.80],0.3212447529144937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,9312,21,2.98 [0.92-9.69],0.0698496824002962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,9317,19,1.58 [0.92-2.74],0.0995238445793511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,9537,22,1.70 [0.84-3.44],0.1393523937534126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,9354,21,1.66 [0.85-3.24],0.1363400185766274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,9253,22,1.19 [0.62-2.27],0.6025829529631984
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,9543,22,0.78 [0.23-2.74],0.7037161974089097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,9564,22,1.69 [1.07-2.69],0.0257862236330412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,9417,21,1.28 [0.86-1.91],0.2174369342240116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,10964,28,1.04 [0.78-1.38],0.7949462566166525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,9784,25,0.52 [0.14-1.85],0.3105529101611112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,9529,22,2.17 [0.85-5.53],0.1050790002310142
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,10964,28,0.90 [0.33-2.45],0.8402337393567758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,9230,19,0.51 [0.31-0.84],0.0085120061134948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,9548,22,1.17 [0.48-2.85],0.7229525972540484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,10831,27,0.96 [0.59-1.55],0.8574897153428973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,9417,21,0.43 [0.14-1.32],0.1401859643492597
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,10778,27,1.05 [0.68-1.61],0.8395778415344531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",9317,19,1.18 [0.72-1.92],0.5048561016095026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",9529,22,1.78 [0.75-4.23],0.1893538501487875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,9543,22,1.51 [0.86-2.65],0.1479314646567449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,10778,27,1.11 [0.53-2.33],0.7885240526761843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,10964,28,1.02 [0.71-1.47],0.9275014553693828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,11019,27,1.01 [0.65-1.55],0.9744716308742578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,9354,21,1.56 [0.97-2.50],0.0666524625017899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,10944,27,1.17 [0.82-1.67],0.3854605527877704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,10944,27,1.10 [0.72-1.68],0.6567651243273835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,10741,27,1.07 [0.71-1.60],0.7557741866261475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,9317,19,0.51 [0.12-2.09],0.3492058180815521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,10926,27,0.96 [0.68-1.34],0.7974743989850204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,10812,26,0.90 [0.54-1.50],0.683119405196338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,9389,22,1.42 [0.57-3.56],0.4533822667367519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,11129,28,1.20 [0.38-3.78],0.7517548954895599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,9564,22,1.03 [0.28-3.73],0.9682124437042616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,9417,21,1.26 [0.75-2.11],0.3903665802105664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,9564,22,0.61 [0.16-2.28],0.4613470390781502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,10778,27,0.87 [0.68-1.12],0.2780852069177038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",9317,19,1.04 [0.33-3.23],0.9494468456116126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,9529,22,0.85 [0.45-1.62],0.6233426146066567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,10778,27,1.04 [0.70-1.55],0.8316259736505827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,9260,21,0.95 [0.34-2.65],0.922372388969519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,11032,27,1.84 [0.40-8.47],0.4331485798736616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,9288,20,1.38 [0.39-4.85],0.6140372708534992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,9404,21,1.00 [0.66-1.50],0.9814871998921908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,9317,19,0.71 [0.33-1.56],0.3976289825815489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,9417,21,1.24 [0.50-3.10],0.6420149463172016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,9580,22,,
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,9253,22,0.70 [0.31-1.61],0.4038146732155568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,10962,28,1.19 [0.80-1.75],0.3928109690397124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,11038,28,0.95 [0.53-1.72],0.863007119564771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,11019,28,1.01 [0.37-2.79],0.9779454241531874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,10992,28,0.99 [0.33-3.00],0.9919272689702062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,10999,27,0.63 [0.25-1.61],0.336594624984706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,11069,28,1.81 [0.78-4.22],0.1688743174045427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,9529,22,0.94 [0.63-1.42],0.778929270793049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,11019,27,1.22 [0.60-2.49],0.5887457906107507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,11138,28,0.68 [0.29-1.61],0.3799512421512001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,9529,22,0.69 [0.31-1.54],0.360679463413244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,10954,28,0.66 [0.18-2.33],0.5134715848144967
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,9288,20,1.07 [0.21-5.51],0.938828711233276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,11032,27,0.95 [0.31-2.86],0.923677609822014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,11148,28,1.92 [0.63-5.87],0.2535440224052914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,11002,27,0.90 [0.57-1.41],0.6423314411898167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,9572,22,3.48 [1.04-11.70],0.0435745404199829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,9210,19,0.48 [0.20-1.11],0.0868456569986468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,11024,27,0.92 [0.26-3.23],0.8975068083441249
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,11006,28,1.18 [0.50-2.77],0.7082622064200181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,11031,28,1.61 [0.79-3.30],0.192835744096573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,10975,27,1.01 [0.34-3.00],0.9786886562205802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,10812,26,1.10 [0.45-2.70],0.8297213862803438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,9260,21,0.76 [0.44-1.33],0.3375979463333852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,9220,20,1.63 [0.54-4.92],0.3888852680700628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,9504,22,1.60 [1.01-2.54],0.0449432097976652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,11122,28,0.92 [0.27-3.13],0.8908889320636625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,10688,26,1.17 [0.89-1.55],0.2582492717480081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,11148,28,1.31 [0.53-3.27],0.5603701731255977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",10760,27,0.66 [0.31-1.41],0.2783100298691983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,9417,21,0.86 [0.25-2.89],0.8018477752742308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,11063,28,0.99 [0.45-2.19],0.9799487398345365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,9564,22,2.20 [0.93-5.19],0.0727601218235645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,9543,22,1.36 [0.86-2.14],0.1859770382859331
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,10910,28,1.10 [0.34-3.61],0.8753719504973839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,9564,22,1.44 [0.40-5.13],0.5747816518154435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,11052,28,1.03 [0.80-1.33],0.8025636928593587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,11006,28,1.09 [0.47-2.56],0.8337572721561799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,10994,26,2.59 [0.57-11.76],0.2185598845810408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,11032,27,1.08 [0.72-1.61],0.7149378761044138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,9253,22,0.90 [0.31-2.58],0.8382549118479394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",9417,21,0.98 [0.38-2.49],0.96215564605003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,9288,20,3.14 [0.76-13.03],0.1150803012437436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,9417,21,0.89 [0.14-5.52],0.9002577598934861
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,11159,28,0.90 [0.53-1.52],0.6834270459595799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,9288,20,0.52 [0.10-2.64],0.433868938820767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,9317,19,1.42 [0.73-2.78],0.3034124083958366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,9417,21,1.36 [0.81-2.29],0.2481957951120811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,9260,21,1.19 [0.58-2.44],0.6380365773282635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,9260,21,0.93 [0.42-2.07],0.865681356377898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,9537,22,1.59 [1.05-2.43],0.0297943837134105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,9529,22,1.17 [0.69-1.97],0.5666411099346405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,9298,19,0.97 [0.48-1.96],0.9407515827128052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,9549,22,0.69 [0.26-1.87],0.4694953489837502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,9230,19,1.01 [0.33-3.06],0.9894142184145648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,9253,22,1.60 [1.18-2.17],0.0022279931519046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,9523,22,0.97 [0.32-2.93],0.954046560334146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,10964,28,0.83 [0.56-1.24],0.3736122161088283
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,10888,27,1.96 [0.76-5.07],0.163240898311582
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,11006,28,1.03 [0.67-1.58],0.8928786806824536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,11063,28,2.23 [1.18-4.19],0.0130543777856311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,10791,26,1.04 [0.38-2.86],0.9404166774124848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,9537,22,1.52 [0.81-2.85],0.1942734040968224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,10831,27,1.09 [0.44-2.72],0.8500668449950453
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,9354,21,1.54 [0.85-2.78],0.154096826745459
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,10944,27,0.57 [0.19-1.75],0.3285931998127366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,10944,27,1.00 [0.40-2.49],0.9933485492571096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,11035,27,0.64 [0.35-1.18],0.1519342450973071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,11159,28,1.51 [0.66-3.45],0.3258594576647594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,10994,28,0.62 [0.19-1.98],0.4176876078353974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,11032,27,0.87 [0.33-2.32],0.78750724025008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,11013,28,0.45 [0.15-1.36],0.1547844164719989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,10831,27,0.93 [0.40-2.13],0.8593627957177854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,11013,28,0.61 [0.19-1.94],0.3979789417294723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,9354,21,2.39 [0.86-6.64],0.0933453555017003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,11112,28,1.83 [0.71-4.71],0.208118834867966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,11006,28,1.49 [0.48-4.61],0.4840206351411881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,11006,28,1.26 [0.60-2.67],0.5375338255995465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,11122,28,1.36 [0.40-4.63],0.6246225009120678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,11138,28,0.65 [0.24-1.76],0.3972544739185205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,10944,27,1.07 [0.60-1.93],0.8142419499338159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,11122,28,0.70 [0.30-1.61],0.4020240997117457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,10944,27,1.23 [0.51-2.98],0.6494908051706885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,11159,28,0.39 [0.11-1.45],0.1596056253310425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,11019,27,1.12 [0.65-1.93],0.693953880823171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,11159,28,0.70 [0.22-2.28],0.5559452586660081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,11052,28,0.70 [0.19-2.53],0.5861650930295611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,11128,28,0.25 [0.07-0.98],0.0465138911027217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,10944,27,0.98 [0.55-1.76],0.9589703195203636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,9577,22,1.12 [0.35-3.59],0.8497407681211422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,9543,22,1.35 [0.88-2.08],0.1697540771172048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,9577,22,1.21 [0.46-3.17],0.6935949202453131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",10812,26,1.21 [0.80-1.84],0.3712917107362954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,9417,21,1.12 [0.37-3.40],0.839310034979075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,10944,27,0.70 [0.31-1.61],0.399644900890085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,11006,28,0.93 [0.25-3.44],0.91410176859221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,9564,22,1.77 [1.11-2.80],0.0154969671007003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,9537,22,1.20 [0.85-1.68],0.3053969428183511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",9230,19,1.87 [1.11-3.16],0.0186552196550552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,9288,20,1.55 [0.96-2.51],0.0706827510462301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,9298,19,1.28 [0.65-2.50],0.472791866981152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,10741,27,0.54 [0.24-1.20],0.1293667049408575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,9288,20,0.88 [0.52-1.48],0.6205233128043592
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,9156,20,1.64 [0.75-3.60],0.213916216168978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,10812,26,0.92 [0.27-3.08],0.8917369839881776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,9317,19,0.65 [0.18-2.35],0.5069172732697425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,9317,19,0.20 [0.04-0.89],0.0345299657112138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,9354,21,1.69 [1.10-2.59],0.0167224622244575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,9564,22,2.67 [0.67-10.61],0.1637935467954872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,9260,21,1.32 [0.58-3.02],0.505588069202497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,10741,27,0.78 [0.47-1.31],0.3522211818162551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,10923,28,0.88 [0.42-1.83],0.7254497752829929
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,9417,21,1.04 [0.62-1.74],0.8738314031556265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,10778,27,0.85 [0.33-2.20],0.7360592724858444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,9260,21,0.77 [0.28-2.14],0.6203930496487045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,9230,19,0.57 [0.22-1.50],0.2554492213169964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,11143,28,1.14 [0.60-2.18],0.6842735461024011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,9549,22,0.68 [0.18-2.55],0.5712330832708616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,9288,20,0.90 [0.19-4.20],0.8909332916018202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,10831,27,1.06 [0.63-1.78],0.8391558791645155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,11019,27,1.18 [0.73-1.90],0.5056469279619498
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",9288,20,1.41 [0.64-3.10],0.3968146473791489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,9260,21,1.42 [0.76-2.64],0.2726925829014963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,9417,21,1.38 [0.91-2.09],0.1264530555794125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,9577,22,1.16 [0.68-2.00],0.5886001639532221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,10994,28,0.87 [0.46-1.65],0.6807793219900238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,9572,22,1.20 [0.58-2.50],0.6263182265057728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,11006,28,0.96 [0.36-2.61],0.9403474893160358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,11112,28,1.13 [0.68-1.89],0.6404265431442393
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,11019,27,0.97 [0.60-1.55],0.8975610537470172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,9397,21,0.86 [0.44-1.68],0.6613680215438272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,9537,22,1.24 [0.85-1.81],0.2554753742507841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,9230,19,1.19 [0.63-2.27],0.5938958254181124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,9317,19,1.01 [0.55-1.84],0.9834136190469884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,11019,27,1.00 [0.68-1.49],0.9868919990329624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,9529,22,1.58 [1.00-2.49],0.0484697176208812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,9260,21,0.34 [0.12-0.99],0.0487055007900894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,9288,20,1.07 [0.64-1.79],0.7988685371961044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,9549,22,1.83 [1.14-2.96],0.013183838906792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,11024,27,1.05 [0.63-1.74],0.8593185130274308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,10812,26,1.27 [0.81-1.99],0.2988171364353734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,9260,21,1.14 [0.40-3.24],0.8122957629022702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,10812,26,1.13 [0.65-1.96],0.6724964751928123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,9260,21,0.65 [0.22-1.98],0.4531540218976918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,9253,22,0.59 [0.30-1.17],0.1288513803223007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,9537,22,0.93 [0.60-1.44],0.731901245431718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,9288,20,1.48 [0.57-3.88],0.4210827664085524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,10763,27,1.09 [0.70-1.71],0.694790537755146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,9317,19,1.19 [0.51-2.77],0.6837678711810053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTN,Titin,9260,21,0.91 [0.48-1.71],0.7706394387761295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,9483,22,0.79 [0.15-4.13],0.7765787977255554
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,9253,22,2.11 [0.74-5.98],0.1602465218399212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,9577,22,1.59 [1.01-2.49],0.0446771692998885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,9417,21,0.89 [0.47-1.69],0.7250628110370839
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,10944,27,1.15 [0.78-1.69],0.4807295349104055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,9428,22,0.98 [0.38-2.50],0.9595874294495524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,11032,27,0.53 [0.17-1.68],0.2794138828756584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,11122,28,1.14 [0.71-1.81],0.584112912624657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,9543,22,1.83 [1.01-3.31],0.0463897457825408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,9237,22,0.81 [0.48-1.36],0.4330732928743045
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",11006,28,1.01 [0.49-2.07],0.9785073997653796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,10953,27,1.00 [0.61-1.65],0.989789931214972
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,11024,27,0.76 [0.23-2.52],0.6485996656354909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",9288,20,1.36 [0.67-2.77],0.3945960130730066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,10964,28,0.41 [0.15-1.14],0.0867485113845846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,9529,22,1.94 [0.55-6.91],0.3060864945677863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,9564,22,1.78 [0.96-3.30],0.0655656758921257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,9288,20,1.31 [0.73-2.35],0.3632701475222213
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,9260,21,0.48 [0.14-1.60],0.2308768163148344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,9354,21,1.46 [0.82-2.61],0.1964421491541202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,9537,22,1.40 [1.03-1.89],0.0294614523884544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,9260,21,0.92 [0.59-1.44],0.7176499554385549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,9260,21,1.33 [0.47-3.78],0.588414246348103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,10944,27,1.49 [0.62-3.60],0.3713077275911826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,11104,28,0.82 [0.46-1.48],0.514086422940024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,9288,20,0.90 [0.18-4.51],0.8941784087497288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,9230,19,1.26 [0.61-2.58],0.531235032965432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,9529,22,1.71 [0.80-3.65],0.1697091777041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,9564,22,0.58 [0.35-0.94],0.0265818367318822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,9253,22,0.84 [0.34-2.06],0.698603190417628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,9395,21,0.76 [0.27-2.15],0.6056354555777987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,9354,21,1.14 [0.61-2.12],0.6827425040976025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,9317,19,0.70 [0.33-1.52],0.3699080144400382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,10964,28,1.19 [0.81-1.75],0.3651883518523832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,9529,22,1.68 [0.97-2.90],0.062255699529193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,9543,22,0.29 [0.06-1.52],0.1436421185465335
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,9260,21,1.12 [0.73-1.72],0.6045905944513996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,10812,26,1.17 [0.82-1.67],0.3746963018920618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,10741,27,0.58 [0.29-1.19],0.1393294131943752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,10812,26,0.70 [0.30-1.61],0.4013904217880442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,9288,20,1.36 [0.85-2.20],0.2036775100237871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,11019,27,1.15 [0.77-1.73],0.4982208471476341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,10857,28,1.12 [0.34-3.73],0.8481626644519629
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,9572,22,1.72 [1.02-2.89],0.0403774751665689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,10964,28,1.27 [0.23-7.10],0.7875826932384201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,9253,22,1.46 [0.97-2.19],0.0690020446261768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,11052,28,0.92 [0.26-3.26],0.8989976083886163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,11122,28,2.79 [0.95-8.23],0.0624074630183932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,9230,19,0.79 [0.39-1.59],0.5138517840414198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,11121,28,1.09 [0.61-1.93],0.776336886646986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,9288,20,1.42 [0.34-5.93],0.6318025564043932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,11032,27,0.80 [0.44-1.46],0.461989735835863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,11140,28,0.98 [0.41-2.34],0.970704208575515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,9549,22,0.99 [0.25-3.89],0.9935207181367246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,10812,26,0.96 [0.72-1.28],0.771895734596625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,9298,19,1.09 [0.22-5.39],0.9128826411137384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,9564,22,1.70 [0.59-4.84],0.3228014587513691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,10964,28,0.85 [0.53-1.35],0.4914281794922057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,9572,22,0.68 [0.41-1.13],0.1382717106438463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,10964,28,0.79 [0.40-1.57],0.5066881165149129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,9417,21,1.49 [0.85-2.59],0.1640206555245469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,10964,28,0.86 [0.56-1.33],0.500818164129512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,9529,22,1.61 [1.08-2.38],0.0185591254155306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,10964,28,1.17 [0.78-1.77],0.4448053499633831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,9529,22,0.39 [0.09-1.66],0.2008244353178465
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,9260,21,2.66 [1.22-5.82],0.0143596182236893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,9529,22,1.32 [0.71-2.46],0.3886664980982544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,10991,28,1.35 [0.59-3.09],0.479117179884686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,11007,27,0.99 [0.57-1.71],0.9690671808555702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,9543,22,0.67 [0.22-2.05],0.4867293288413137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,10778,27,0.54 [0.26-1.12],0.0997481175121434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,9417,21,1.15 [0.44-2.96],0.7759415615019943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,10812,26,1.30 [0.81-2.10],0.277224775606483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,11122,28,0.99 [0.61-1.60],0.9637067364326544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,10741,27,1.67 [0.58-4.78],0.3415381387198879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,9354,21,1.63 [0.86-3.07],0.1343251423305758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,11101,28,0.59 [0.27-1.29],0.1844374952031811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,9230,19,0.93 [0.49-1.79],0.8329846424487029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,10906,27,2.29 [1.00-5.29],0.0513752344354416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,9549,22,1.31 [0.67-2.59],0.4302348704119693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,11148,28,1.07 [0.69-1.66],0.7689855424472521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",11006,28,0.92 [0.38-2.21],0.8476005260468664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,10831,27,0.93 [0.55-1.57],0.7821006936490703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,10812,26,1.18 [0.83-1.68],0.3511660578062735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,10778,27,0.99 [0.67-1.46],0.9429384317518772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,9543,22,1.35 [0.86-2.13],0.1921912625760415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,9288,20,1.20 [0.68-2.10],0.5264851181374193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,9529,22,0.59 [0.16-2.18],0.4286473441812323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,9325,21,0.66 [0.24-1.79],0.411887033857122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,11089,28,0.59 [0.34-1.03],0.0654003232180889
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,10450,27,1.09 [0.44-2.73],0.8484201298595787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",10903,27,0.74 [0.31-1.75],0.493092161278822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",11013,28,0.70 [0.28-1.76],0.4468413171719954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,11112,28,0.99 [0.37-2.69],0.9908710760856602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,10831,27,0.39 [0.11-1.44],0.156693055015867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,10944,27,1.08 [0.56-2.06],0.8210262469730549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,11112,28,1.10 [0.61-1.96],0.7582890922731432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,11092,28,0.73 [0.31-1.71],0.4641090110633931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,9288,20,1.57 [0.82-3.03],0.1758799447341456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,11032,27,0.81 [0.61-1.07],0.1411218314384202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,10778,27,1.82 [0.90-3.68],0.0953844198421689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,9543,22,1.90 [0.57-6.32],0.2963386978859462
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",9537,22,1.49 [1.08-2.04],0.0146466493537098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,10964,28,1.04 [0.78-1.39],0.7894850697976794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,9529,22,1.35 [0.42-4.41],0.614021591233523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,9260,21,1.10 [0.55-2.18],0.7864512765837813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,10831,27,1.06 [0.71-1.58],0.7753757485920888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,9354,21,1.75 [1.03-2.99],0.039913254318617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,9288,20,2.39 [0.68-8.38],0.1742705713095228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,9288,20,1.13 [0.44-2.87],0.800128504607037
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,10741,27,1.04 [0.66-1.63],0.8721235152165536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,10812,26,1.13 [0.52-2.46],0.7567473375160712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,9260,21,0.67 [0.28-1.61],0.3695053362954429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,9537,22,1.63 [1.04-2.55],0.0323900251042494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,9543,22,0.63 [0.13-3.13],0.5756502355648709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,9288,20,1.05 [0.33-3.33],0.929411543714424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,9417,21,1.15 [0.65-2.04],0.6354390913828999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,9529,22,0.89 [0.51-1.54],0.6741377944498894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,9537,22,1.41 [0.83-2.41],0.2020045332334783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,9529,22,1.38 [0.68-2.82],0.3755300153276483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,9298,19,1.05 [0.88-1.25],0.6130958901882003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,9230,19,0.86 [0.20-3.72],0.8394411627771297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,9253,22,1.10 [0.72-1.66],0.6645166032618364
